- About MICAD
- MRI
- 13C
- Hyperpolarized [1,4-13C2]fumarate as an imaging agent of tumor cell death in vivo
- Hyperpolarized [1-13C]dehydroascorbic acid
- Hyperpolarized [13C]-2-hydroxyethylpropionate
- Hyperpolarized 13C-labeled bicarbonate (H13CO3-) for in vivo pH measurement with 13C magnetic resonance spectroscopy
- Hyperpolarized sodium 1-[13C]pyruvate
- Hyperpolarized α-keto[1-13C]isocaproate as a 13C magnetic resonance spectroscopic agent for profiling branched chain amino acid metabolism in tumors
- 19F
- Cu
- Europium
- Fe
- Gadolinium
- (1-(2-(β-Galactopyranosyloxy)propyl)-4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane) gadolinium(III)
- (Gd-chelate)2-Phe-His-Cys-Pro(OH)-Tyr(2-Cl)-Asp-Leu-Cys-His-Ile-Leu-(Gd-chelate)2
- [(Biotin-Ala-Ser-Lys-Lys-Pro-Lys-Arg-Asn-Ile-Lys-Ala)4-dendrimer]-streptavidin-[biotin-gadolinium 1,4,7-tris(carboxymethyl)-10-(2’-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-loaded apoferritin]
- 4,5-Diethyl-10,23-dimethyl-9,24-bis(3-hydroxypropyl)-16,-17-bis(3,hydroxypropyl)oxy-13,20,25,26,27—pentaazapentacyclo-[20.2.1.13,6.19,11.014,19]heptacosa-3,5,8,10,12,14,16,18,20,22,24-undecaene gadolinium hydrates
- Anti-c-Met monoclonal antibody linked to biotinylated bovine serum albumin and gadolinium
- Anti-intercellular adhesion molecule 1 antibody–conjugated gadolinium diethylenetriaminepentaacetic acid
- Anti-malondialdehyde-modified low-density lipoprotein MDA2 monoclonal antibody gadolinium-labeled micelles
- Anti-vascular endothelial growth factor polylactic acid-polyethylene glycol-poly-L-Lys/gadolinium-diethylenetriamine pentaacetic acid nanoparticles
- Avidin-gadolinium
- Biotinylated bovine serum albumin linked to gadolinium diethylenetriaminepentaacetic acid
- Dimeric Gd-tetraazacyclododecanetetraacetic acid-folate
- Evans Blue-diethylenetriamine-N,N,N”,N”-pentaacetic acid-gadolinium
- Folate-polyethylene glycol-ultrasmall superparamagnetic iron oxide nanoparticles
- Gadobenate
- Gadobutrol
- Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-cinnamoyl-Phe-D-Leu-Phe-D-Leu-Phe-Lys-NH2
- Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-G3 nanoglobule-CGLIIQKNEC (CLT1)
- Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-Lys-polyethylene glycol-CGLIIQKNEC (CLT1)
- Gadolinium-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-icosahedral closo-borane12 scaffold conjugated with Glu-{Glu-[cyclo(Arg-Gly-Asp-d-Phe-Lys)]2}2
- Gadolinium-1,4,7,10-tetraazacyclododecane-N,N’,N’,N’”-tetraacetic-monoamide-24-cascade-polymer
- Gadolinium-1,4,7,10-tetraazacyclododecane-N',N'',N''',N''''-tetraacetic acid-Gly-Pro-D-Leu-D-Ala-NHOH
- Gadolinium-1,4,7,10-tetraazacyclododecane-N',N'',N''',N''''-tetraacetic acid-Pro-Leu-Ala-Leu-Lys-Arg-Asp-Arg
- Gadolinium 1-((11-S)-3,10-diaza-13-carboxamido-11-carboxy-2,9-dioxotridecyl)-N,N’,N”-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane
- Gadolinium-anti-neutrophil gelatinase-associated lipocalin 2 24p3 antibody-conjugated micelles
- Gadolinium-bis-5-hydroxytriptamide-diethylenetriamine pentaacetic acid
- Gadolinium-diethylenetriamine pentaacetic acid-24-cascade-polymer
- Gadolinium diethylenetriamine pentaacetic acid-Arg-Gly-Asp peptidomimetic
- Gadolinium-diethylenetriamine pentaacetic acid-carboxymethylarabinogalactan
- Gadolinium-diethylenetriamine pentaacetic acid-GKWHCTTKFPHHYCLY
- Gadolinium-Diethylenetriamine pentaacetic acid-Leu-Ile-Lys-Lys-Pro-Phe
- Gadolinium-Diethylenetriamine pentaacetic acid-poly(lactic-co-glycolic acid) microbubbles
- Gadolinium-diethylenetriamine tetraacetic acid-icosahedral closo-borane12 scaffold
- Gadolinium-Hexyl-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid-progesterone
- Gadolinium-HU-308-incorporated micelles
- Gadolinium-incorporated mesoporous silica nanoparticles
- Gadolinium-labeled diethylenetriamine pentaacetic acid-CGLIIQKNEC
- Gadolinium-reconstituted high-density liproprotein-[palmitoyl-WK(palmitoyl)G(LRKLRKRLLR)2-NH2] nanoparticles
- Gadolinium-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-Cys-Asn-Asn-Ser-Lys-Ser-His-Thr-Cys
- Gadolinium-tetraazacyclododecane tetraacetic acid coupled with folate via bis(aminoethyl)ethylene glycol linker
- Gadoteridol Gd-HP-DO3A
- GadoversetamideGd-DTPA-BMEA
- Gadoxetate
- Gd@C82 Fullerenol
- Gd-Diethylenetriaminepentaacetic acid-polylysyl-N-glutaryl-phosphatidyl ethanolamine-2C5 liposomes
- Gd-DOTA-anti-Aβ42-F(ab’)2-antibody fragment (putrescine)n
- Gd-DOTA-c(Cys-Arg-Gly-Asp-Cys)
- Gd-DOTA-G-NH(CH2)11CO-RSPAYYTAA-(CH2CH2O)8-R
- Gd-DTPA-Bz-poly(α,L-glutamic acid)
- Gd-DTPA-Cystine diethyl ester copolymers
- Gd-DTPA l-Cystine bisamide copolymers
- Gd-DTPA l-Cystine bisisopropyl amide copolymers
- Gd-DTPA l-Cystine bispropyl amide copolymers
- GKVLAK–(Gadolinium-(1,4,7,10-tetraazacyclododecane-1,4,7-tris(acetic acid t-butyl ester)-10-acetic acid monoamide))–GGGGTVQQEL
- Mouse anti-cMet monoclonal antibody linked to gadolinium diethylenetriamine pentaacetic acid conjugated to biotinylated bovine serum albumin
- Poly(ethylene glycol)-b-poly(L-lysine)-gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid micelle
- Polyion complex micelles of poly(ethylene glycol)-b-poly(L-lysine)-gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-dextran sulfate
- Pyridine-tetra-acetate-gadolinium(III) (PTA-Gd) conjugated to 17β-estradiol (EPTA-Gd) or tamoxifen (TPTA-Gd)
- TAMRA-IL-13-Conjugated functionalized gadolinium metallofullerene (Gd3N@C80(OH)-26(CH2CH2COOH)-16)
- Transferrin-coated gadolinium-labeled human serum albumin nanoparticles
- Tri-gadolinium nitride PEGylated-hydroxylated endohedral metallofullerene
- Trisodium-[(2-(R)-[(4,4-diphenylcyclohexyl)phosphono-oxymethyl]-diethylenetriaminepentaacetato)(aquo)gadolinium(III)Gadofosveset
- Iron oxide
- Amine-modified silica-coated polyhedral superparamagnetic iron oxide nanoparticle–labeled rabbit bone marrow–derived mesenchymal stem cells
- Anti-ligand–induced binding sites (LIBS) antibody conjugated to microparticles of iron oxide
- Anti-malondialdehyde-modified low-density lipoprotein MDA2 monoclonal antibody–labeled lipid-coated superparamagnetic iron oxide nanoparticles
- Anti-malondialdehyde-modified low-density lipoprotein MDA2 monoclonal antibody–labeled lipid-coated ultra-small superparamagnetic iron oxide nanoparticles
- Anti-vascular cell adhesion molecule antibody M/K-2.7 and anti-P-selectin antibody RB40.34 conjugated microparticles of iron oxide
- Anti-vascular cell adhesion molecule antibody M/K-2.7–conjugated microparticles of iron oxide
- Avidin-coated baculoviral vectors-biotinylated ultra-small superparamagnetic iron oxide nanoparticles
- Citrate-coated (184th variant) very small superparamagnetic iron oxide particles
- CLIO-(H-2Kd)-Lys-Tyr-Asp-Lys-Ala-Asp-Val-Phe-Leu
- Complement receptor type 2–conjugated superparamagnetic iron oxide nanoparticles
- Cross-linked iron oxide–transactivator transcription
- Cyclo(Arg-Gly-Asp-D-Try-Glu) conjugated to ultrasmall superparamagnetic iron oxide nanoparticles
- Doxorubicin-loaded poly(ethylene oxide)-trimellitic anhydride chloride-folate superparamagnetic iron oxide nanoparticles
- Ferumoxides
- Ferumoxsil
- Ferumoxtran
- FluidMAG iron nanoparticle-labeled mesenchymal stem cells for tracking cell homing to tumors
- Glycol chitosan/heparin-immobilized gold-deposited iron oxide nanoparticles
- H18/7 F(ab’)2 E-selectin monoclonal antibody conjugated to cross-linked iron oxide nanoparticles
- Iron oxide–ferritin nanocages
- Iron oxide nanoparticles-poly-L-lysine complex
- Lactoferrin-conjugated poly(ethylene glycol)-coated Fe3O4 nanoparticles
- Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles
- Magnetic iron microbeads coupled with HEA-125 monoclonal antibody against epithelial cell adhesion molecule
- MES-1 F(ab’)2 E-selectin monoclonal antibody conjugated to ultrasmall superparamagnetic iron oxide nanoparticle
- Monoclonal antibody against antigen A7 coupled to ferromagnetic lignosite particles
- N-Alkyl-polyethylenimine 2 kDa–stabilized superparamagnetic iron oxide nanoparticles for MRI cell tracking
- Octreotide conjugated to pegylated ultrasmall superparamagnetic iron oxide nanoparticle
- Ovarian cancer antigen 183B2 monoclonal antibody conjugated to ultrasmall superparamagnetic iron oxide nanoparticles
- Poly(N,N-dimethylacrylamide)-coated maghemite nanoparticles for labeling and tracking mesenchymal stem cells
- Polyethylene glycol–coated and folic acid–conjugated superparamagnetic iron oxide nanoparticles
- Saposin C-dioleylphosphatidylserine nanovesicles coupled with iron oxides
- Sialy Lewisx mimetic conjugated to pegylated ultrasmall superparamagnetic iron oxide nanoparticles
- Sialy Lewisx mimetic conjugated to ultrasmall superparamagnetic iron oxide nanoparticles
- Single-chain anti-epidermal growth factor receptor antibody fragment conjugated to magnetic iron oxide nanoparticles
- Superparamagnetic iron oxide nanoparticles (SPION) stabilized by alginate
- Thermally cross-linked superparamagnetic iron oxide nanoparticle-A10 RNA aptamer-doxorubicin conjugate
- Thiol-modified poly(ethylene glycol)-conjugated gold/superparamagnetic iron oxide nanoparticles
- Trastuzumab-dextran iron oxide nanoparticles
- Trastuzumab-manganese–doped iron oxide nanoparticles
- Ultrasmall superparamagnetic iron oxide-anti-CD20 monoclonal antibody
- Ultrasmall superparamagnetic iron oxide-cyclo(Cys-Asn-Asn-Ser-Lys-Ser-His-Thr-Cys)
- Ultrasmall superparamagnetic iron oxide-Leu-Ile-Lys-Lys-Pro-Phe
- Ultrasmall superparamagnetic iron oxide nanoparticles conjugated with Ile-Pro-Leu-Pro-Phe-Tyr-Asn
- ZHER2:342 Affibody-polyethylene glycol-superparamagnetic iron oxide nanoparticles
- Manganese ferrite
- Anti-malondialdehyde-modified low-density lipoprotein MDA2 murine monoclonal antibody manganese-micelles
- Manganese(II)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-G3 nanoglobule-CGLIIQKNEC (CLT1)
- Vascular endothelial growth factor A isoform 121-gelonin fusion protein–conjugated manganese ferrite nanoparticles
- Nitroxide
- Nitroxide
- Tm3+
- Yb
- 13C
- Multimodal
- 111In, 68Ga
- 111In/68Ga-Labeled anti-epidermal growth factor receptor, native chemical ligation cyclized Affibody ZHER2:342min
- 111In/68Ga-Labeled DOTA-conjugated cyclo[γ-d-Glu-Ala-Tyr-d-Lys]-Trp-Met-Asp-Phe-NH2 (cyclo-MG1), a minigastrin analog
- 111In/68Ga-Labeled DOTA conjugated cyclo[γ-d-Glu-Ala-Tyr-d-Lys]-Trp-Nle-Asp-Phe-NH2 (cyclo-MG2), a minigastrin analog
- 111In, Cy5.5
- 111In, Cy7
- 111In, CyAL5.5
- 111In and IRDye800
- 111In and IRDye 800CW
- 123I, 124I
- 124I, 125I
- 177Lu, cypate
- 64Cu, Cy5.5
- 64Cu, cypate
- 64Cu, quantum dot (QD705)
- 64Cu and Acridine
- 64Cu and IRDye800
- 64Cu-1,4,7-Triazacyclononane-1,4,7-triacetic acid-p-isothiocyanatobenzyl-bevacizumab-IRDye 800CW
- 64Cu-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-conjugated IRDye 800CW (a near-infrared fluorescence dye) coupled to mAb7, an anti-epithelial cell adhesion molecule monoclonal antibody
- 64Cu-Labeled NOTA-conjugated anti-CD105 (endoglin) chimeric monoclonal antibody linked to near-infrared dye IRDye 800CW
- 64Cu and LRhodamine
- 64Cu and quantum dot
- 66/67/68Ga
- 67Ga, 68Ga
- 89Zr and IRDye 800CW
- 99mTc, iodine
- Alexa Fluor 680, gadolinium
- Au, gadolinium (Gd)
- Cy5.5, gadolinium (Gd)
- Cy5.5, gadolinium (Gd), gold (Au)
- Europium, perfluorocarbon
- Gadolinium, Texas Red
- Gadolinium (Gd3+), quantum dots (QDs)
- Gold nanoparticles, Cy5.5
- I (as iohexol); Gd (as gadoteridol)
- IR-783 and 111In
- Iron, GFP
- Iron oxide, 111In
- Iron oxide, 124I
- Iron oxide, Cy5.5
- Annexin V-cross-linked iron oxide-Cy5.5
- Anti-vascular cell adhesion molecule monoclonal antibody M/K-2.7 conjugated cross-linked iron oxide-Cy5.5 nanoparticles
- Cross-linked iron oxide-Cy5.5
- Cy5.5-Amino-terminal fragment of urokinase-type plasminogen activator conjugated to magnetic iron oxide nanoparticles
- Cy5.5-Arg-Arg-Arg-Arg-crosslinked iron oxide nanoparticle
- Gly-Ser-Ser-Lys-(FITC)-Gly-Gly-Gly-Cys-Arg-Gly-Asp-Cys-CLIO-Cy5.5
- Green fluorescent protein specified small interfering RNA-cross-linked iron oxide nanoparticles-Cy5.5
- IPLVVPLGGSC(Cy5.5-Cross-linked iron oxide)K(Fitc)
- Lys-Thr-Leu-Leu-Pro-Thr-Pro-cross-linked iron oxide-Cy5.5
- Survivin specified small interfering RNA-CLIO-Cy5.5
- VCAM-1 internalizing peptide-28 nanoparticles
- Iron oxide, Cy5.5, FITC
- Iron oxide, Cy7
- Iron oxides, RITC
- Iron oxides, VT680, 64Cu
- Microspheres, 166Ho
- Quantum dot, gadolinium
- 111In, 68Ga
- Optical
- 5-Carboxy-fluorescein
- A15
- Alexa Fluor 488
- Alexa Fluor 647
- Alexa Fluor 680
- Alexa 680 conjugated to bovine serum albumin
- Alexa Fluor 680-Bevacizumab
- Alexa Fluor 680-glycylglycylglycine-bombesin[7-14]NH2 peptide
- Alexa Fluor 680-NH-CO-CH2-S-CH2-Phe-Pro-Arg-CH2-prothrombin
- Humanized anti–type 1 insulin-like growth factor receptor monoclonal antibody conjugated to Alexa 680
- LLP2A-biotin-streptavidin-Alexa Fluor 680
- Self-quenching Alexa fluor 680 conjugated to trastuzumab
- Alexa Fluor 700
- Alexa Fluor 750
- AOI987
- Au
- BODIPY-FL
- BODIPY TMR-X
- CellVue Maroon
- Cy5
- Carbobenzoxy-capped Phe-Lys(Cy5)-acyloxymethyl ketone
- Cbz-Phe-Lys(Cy5)-methyl ketone-2,6,dimethylterephthalic amide-hexyl-QSY 21
- Cy5-Glu-Pro-Asp-acyloxymethyl ketone
- Cy5-labeled aza-peptidyl Pro-Asn epoxide
- Cy5-Regioselectively addressable functionalized template-[cyclo-(RGD-d-Phe-Lys)]4 peptide
- Cy5-Tat-Glu-Pro-Asp-acyloxymethyl ketone
- L36-Cy5 anti-laminin trimerbody
- MFE23-Cy5 anti-carcinoembryonic antigen trimerbody
- Recombinant human erythropoietin coupled to near-infrared fluorescence dye Cy5.5
- Self-quenched-regioselectively addressable functionalized template-[cyclo-(RGD-d-Phe-Lys)]4 peptide-Cy5-fluorescence quencher QSY21
- Cy5.5
- 2-(1E,3E,5E)-5-3-(R)-1-(1-(R)-2-(R)-2-[2-(4-(Benzo[d]thiazol-2-ylamino)phenyl)\acetamido]-6-(E)-3-(pyridin-3-yl)acrylamido)hexanamido)-5-carboxypentanamido)cyclohexyl)-27-carbamoyl-1,9,13,21,25,33-hexaoxo-5,17-dioxa-2,8,14,20,26,32-hexa-azaheptatriacontan-37-yl)-1,1-dimethyl-6,8-disulfonato-1H-benzo[e]indol-2(3H)-ylid-ene)penta-1,3-dienyl)-3-ethyl-1,1-dimethyl-1H-ben-zo[e]indolium-6,8-disulfonate
- Chlorotoxin:Cy5.5
- Cy5.5-3-Benzo[1,3]dioxol-5-yl-5-hydroxy-5-(4-methoxyphenyl)-4-(3,4,5-trimethoxybenzyl)-5H-furan-2-one)
- Cy5.5-8-Amino-octanoic acid-Ser-Cys-Pro-Pro-Trp-Gln-Glu-Trp-His-Asn-Phe-Met-Pro-Phe-NH2
- Cy5.5-Ac-Cys-ZEGFR:1907
- Cy5.5-Aminohexanoic acid-RPLALWRS-aminohexanoic acid-C-G4-PAMAM-PEG-AF750
- Cy5.5-Annexin V
- Cy5.5-Anti-ephrin receptor B4 (EphB4) humanized monoclonal antibody hAb47
- Cy5.5-Asp-Gly-Glu-Ala (DGEA)
- Cy5.5-Asp-Gly-Glu-Ala-Gly-Lys-(Arg)8-OH
- Cy5.5-c(Lys-Ala-His-Trp-Gly-Phe-Thr-Leu-Asp)NH2
- Cy5.5-CGRRRQRRKKRG-Labeled T lymphocytes
- Cy5.5-Chitosan-anti-vascular endothelial growth factor receptor 2 monoclonal antibody DC101
- Cy5.5 conjugated anti-epidermal growth factor receptor monoclonal antibody
- Cy5.5-Conjugated anti-epidermal growth factor receptor monoclonal antibody C225
- Cy5.5-Conjugated anti-human CD31 monoclonal antibody
- Cy5.5-Conjugated glycol chitosan-5β-cholanic acid nanoparticles
- Cy5.5-Conjugated matrix metalloproteinase cleavable peptide nanoprobe
- Cy5.5-Cyclo(CGNSNPKSC)
- Cy5.5-Endostatin
- Cy5.5-Epidermal growth factor
- Cy5.5-Ferritin nanocages
- Cy5.5-GGPRQITAGK(Fitc)C-Poly-L-lysine-methoxypolyethylene glycol
- Cy5.5-GGSGRSANAK(Fitc)C-poly-L-lysine-methoxy polyethylene glycol
- Cy5.5-Gly-His-Pro-Gly-Gly-Pro-Gln-Gly-Lys(Fitc)-Cys-Poly-L-lysine-methoxypolyethylene glycol
- Cy5.5-Gly-Pro-Leu-Gly-Val-Arg-Gly-(TDOPA)3-flower-like gold–Fe3O4 optical nanoparticles
- Cy5.5-Gly-Pro-Leu-Gly-Val-Arg-Gly-Cys-Ferritin-black hole quencher-3 nanocages
- Cy5.5-Gly-Pro-Leu-Gly-Val-Arg-Gly-Cys-gold nanoparticles
- Cy5.5-Human serum albumin-tissue inhibitor of matrix metalloproteinase 2 fusion protein
- Cy5.5-Knottin 2.5D
- Cy5.5-Knottin 2.5F
- Cy5.5-labeled pH low insertion peptide (pHLIP)
- Cy5.5-Polyethylene glycol-CGS25966 inhibitor of matrix metalloproteinases
- Cy5.5-Poly-L-lysine-methoxypolyethylene glycol
- Cy5.5-Rituximab
- Cy5.5-Single-chain Cys-tagged vascular endothelial growth factor-121
- Cy5.5-Trastuzumab
- Cyclo(Arg-Gly-Asp-d-Tyr-Lys)-Cy5.5
- Cyclo(Cys-Arg-Gly-Asp-Cys)-Gly-Lys-Cy5.5
- Cyclo(Cys-Asn-Gly-Arg-Cys)-Gly-Lys-Cy5.5
- Cys-Arg-Lys-Arg-Leu-Asp-Arg-Asn-Cys-glycol chitosan-Cy5.5 nanoparticles
- D-Cys-D-Asp-Gly-HCit-Gly-Pro-Gln-D-Cys-Ebes-Ebes-Lys-Cy5.5
- D-Cys-D-Asp-Gly-HCit-Gly-Pro-Gln-D-Cys-Ebes-Lys-polyethylene glycol-cholic acids-Cy5.5 telodendrimer nanoparticles
- D-Cys-D-Asp-Gly-Leu-Gly-ProOH-Asn-D-Cys-biotin-streptavidin-Cy5.5
- D-Cys-D-Asp-Gly-Tyr(3-NO2)-Gly-ProOH-Asn-D-Cys-biotin-streptavidin-Cy5.5
- Fibroblast activation protein α–specific, near-infrared peptide probe (KGPGPNQC) linked to Cy5.5 and a quencher dye, QSY21
- Mesenchymal-epithelial transition factor binding peptide-8-aminooctanoic acid conjugated to Cy5.5
- Mesenchymal-epithelial transition factor binding peptide-Gly-Gly-Gly conjugated to Cy5.5
- Sialyl-Lewisx-liposome-Cy5.5
- Cy7
- Cypate
- DiD
- DiR
- DY675
- DY682
- DY750
- Fluorescein
- Fluorescein isothiocyanate (FITC)
- Green fluorescence protein
- Green fluorescence protein (GFP), luciferin
- HiLyte Fluor 647
- IANBD
- Indocyanine green
- Anti-human sperm protein 17 monoclonal antibody-indocyanine green derivative 02
- Bovine serum albumin–stabilized gold nanoclusters conjugated with folate and indocyanine green derivative 02
- Bovine serum albumin–stabilized gold nanoclusters conjugated with l-methionine and indocyanine green derivative 02
- Daclizumab complexed to near-infrared fluorophore indocyanine green
- Folic acid-indocyanine green-poly(d,l-lactide-coglycolide)-lipid nanoparticles
- Indocyanine green derivative 02-2-deoxy-d-glucose
- Indocyanine green derivative 02-Glu-c(RGDyK)2
- Indocyanine green–doped calcium phosphate nanoparticles
- Indocyanine green-polyethylene glycol-folate
- l-Methyl-methionine-indocyanine green derivative 02
- Quenched indocyanine green-anti-prostate-specific membrane antigen antibody J591
- Trastuzumab complexed to near-infrared fluorophore indocyanine green
- Indocyanine green and Alexa Fluor680
- IR-783
- IR-786
- IR-820
- IR-820 and FITC
- IRDye700DX
- IRDye78
- IRDye 800CW
- Biotinylated vascular endothelial growth factor121-Avi-streptavidin-IRDye800
- Humanized anti-CD44v6 monoclonal antibody labeled with IRDye800CW
- IRDye800-2-(3-{5-[7-(5-amino-1-carboxy-pentylcarbamoyl)-heptanoylamino]-1-carboxy-pentyl}-ureido)-pentanedioic acid
- IRDye800-2-Deoxy-D-glucose
- IRDye 800-albumin-binding domain-fused-ZHER2:342 Affibody
- IRDye 800-Anti–epidermal growth factor receptor Affibody
- IRDye800-Anti-vascular endothelial growth factor receptor-2 monoclonal antibody Avas12a1
- IRDye800CW-anti-CD105 TRC105 chimeric monoclonal antibody
- IRDye 800CW-Anti-epidermal growth factor receptor nanobody 7D12
- IRDye800CW-Cyclic albumin-binding domain (Ac-RLIEDICLPRWGCLWEDDK-NH2)
- IRDye 800CW-Epidermal growth factor
- IRDye 800CW-Human serum albumin
- Near-infrared Dye®800CW–conjugated disulfide-based cyclic RGD peptide c(CRGDKGPDC) and its DOTA analog
- Near-infrared dye IRDye 800CW-labeled butyrylcholinesterase
- IRIS Blue
- Luciferin
- Malachite green
- NIAD-4
- NIR2
- Oregon Green 488
- Pyropheophorbide α (Pyro)
- Quantum dot (QD)
- Anti-α-Fetoprotein antibody-quantum dots
- Arginine-glycine-aspartic acid peptide-labeled quantum dot 705
- Epidermal growth factor conjugated to near-infrared fluorescent quantum dots
- Humanized anti–type 1 insulin-like growth factor receptor monoclonal antibody conjugated to cadmium telluride quantum dots
- Ligand-conjugated, gold-doped CdHgTe quantum dots for multispectral imaging
- QD800-Anti-epidermal growth factor receptor monoclonal antibody nanoparticles
- QD800-Polyethylene glycol-Cys-ZHER2:342 Affibody
- Quantum dot 800-conjugated anti-Tn IgM 2154F12A4 murine monoclonal antibody
- Quantum dot 800–mercaptopropionic acid
- Quantum dot800-poly(ethylene glycol)-c(Arg-Gly-Asp-d-Tyr-Lys)
- Quantum dot 800–prostate-specific membrane antigen antibody J591
- Quantum dot-A10 RNA aptamer-doxorubicin conjugate
- Quantum dot-prostate-specific membrane antigen antibody J591
- Quantum dots-deoxycholic acid (DOCA)-conjugated low molecular weight heparin (LMWH) nanoparticles
- Quantum dot-trastuzumab
- Single-chain anti-epidermal growth factor receptor antibody fragment conjugated to functionalized quantum dots
- Rhodamine green (RhodG)
- RhodamineX
- SIDAG
- Single-walled carbon nanotubes (SWNTs)
- Tetramethyl-6-carboxyrhodamine
- Tetramethylrhodamine
- THK-265
- TOTO-3
- VivoTag 750
- VivoTag-S680
- VM315
- ZW800-1
- PET
- 11C
- (-)-3-(4-Chlorophenyl)-N'-[(4-[11C]cyanophenyl)sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine
- (-)-4-[11C]Methoxycarbonyl-2-[(1-pyrrolidinylmethyl]-1-[(3,4-dichlorophenyl)acetyl]-piperidine
- (-)-N-[11C]Propyl-norapomorphine
- (+/-)-2-(N-Cyclohexylethyl-N-[11C]propyl)amino-5-hydroxytetralin
- (+/-)-2-(N-Phenethyl-N-1'-[11C]propyl)amino-5-hydroxytetralin
- (+)-(2S,3S)-3-(2-[11C]Methoxybenzylamino)-2-phenylpiperidine
- (+)-8-Chloro-5-(7-benzofuranyl)-7-hydroxy-3-[11C]methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
- (+)-p-[11C]Methylvesamicolphenoxy)
- (1R,2R)-N-(3-(4-[11C]Methoxyphenyl)-4-methylisothiazol-5-yl)-2-methylcyclopropane-carboxamide
- (20R)-4,5-α-Epoxy-17-methyl-3-hydroxy-6-[11C]methoxy-α,17-dimethyl-α-(2-phenylethyl)-6,14-ethenomorphinan-7-methanol
- (2-methoxy-11C)-N-(4-(3,4-Dihydro-6,7-dimethoxy-isoquinolin-2(1H)-yl)butyl)-5-methylbenzamide
- (2S,3S)-(2-[11C]Methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine
- (2S,3S)-2-[α-(2-[11C]Methylphenoxy)phenylmethyl]morpholine
- (2S,3S)-N-[[2-[11C]Methoxy-5-[5-(trifluoromethyl)tetrazol-1-yl]phenyl]methyl]-2-phenyl-piperidin-3-amine
- (3-Ethyl-2-[11C]methyl-6-quinolinyl)(cis-4-methoxycyclohexyl)methanone
- (3R,5R)-3-((R)-1-(4-Fluorophenyl)ethylamino)-5-(3-[11C]methoxyphenyl)-1-(4-trifluoromethylphenyl)pyrrolidin-2-one
- (3R,5R)-5-(3-[11C]Methoxy-phenyl)-3-((R)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one
- (R,S)-1,2,3,4,10,14b-Hexahydro-2-[11C]methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine
- (R,S)-2-(N-Propyl-N-1'-[11C]-propyl)amino-5-hydroxytetralin
- (R)-(-)-2-Chloro-N-[1-11C-propyl]n-propylnorapomorphine
- (R)-(+)-8-Chloro-2,3,4,5-tetrahydro-3-[11C]methyl-5-phenyl-1H-3-benzazepin-7-ol ([11C]SCH 23390)
- (R)-2,3,4,5,6,7-Hexahydro-1-[4-[1-[4-(2-[11C]methoxyphenyl)piperazinyl]]-2-phenylbutyryl]-1H-azepine
- (R)-2-[11C]Methoxy-N-n-propylnorapomorphine
- (S,S)-[11C]Methylreboxetine
- (S)-1-(4–2-[11C]Methoxybenzyl)-5-(2-phenoxymethyl-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- (S)-5-Methoxymethyl-3-[6-(4,4,4-trifluorobutoxy)benzo[d]isoxazol-3-yl]-oxazolidin-2-[11C]one
- (S)-6-[(4-Chlorophenyl)(1H-1,2,4-triazol-1-yl)methyl]-1-[11C]methyl-1H-benzotriazole
- (S)-N-(1-Ethyl-2-pyrrolidinyl)methyl)-5-bromo-2-[11C]methoxy-3-methoxybenzamide
- [11C](+)-4-N-Propyl-,3,4a,5,6,10b-hexahydro-2H-naphth[1,2-b][1,4]-oxazin-9-ol
- [11C](5R)-5-(Methoxymethyl)-3-[4-[(3R)-4,4,4-trifluoro-3-hydroxybutoxy]phenyl]-2-oxazolidinone
- [11C]-[N-Methyl]3-[(3-fluorophenyl)sulfonyl]-8-(4-methyl-1-piperazinyl)quinoline
- [11C]10-Methoxy-5-(2-propenyl)-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinoline
- [11C]2-(2-((Dimethylamino)methyl)phenylthio)-5-(2-fluoroethyl)phenylamine
- [11C]2-(2-(Dimethylaminomethyl)phenylthio)-5-fluoromethylphenylamine
- [11C]2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6-(2-[fluoro]ethoxy)benzoxazole
- [11C]2-(Dimethylamino)-N-(5,6-dihydro-6-oxophenanthridin-2-yl)acetamide
- [11C]2-2-(Dimethylaminomethyl)phenylthio)-5-fluorophenylamine
- [11C]4-N-Methylamino-4´-hydroxystilbene
- [11C]5-Hydroxy-2-(4-methyaminophenyl)benzofuran
- [11C]Acetate
- [11C]Acetoacetate
- [11C]Carfentanil
- [11C]Choline
- [11C]Glycylsarcosine
- [11C]meta-Hydroxyephedrine
- [11C]Methylated LY2181308
- [11C]N,N-Dimethyl-2-(2´-amino-4´-hydroxymethylphenylthio)benzylamine
- [11C]N,N-Dimethyl-2-(2-amino-4-cyanophenylthio)benzylamine
- [11C]N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine
- [11C]N-Methyl-N-phenyl-[2-(4-chlorophenyl)-6,8-dichloroimidazo[1,2-a]pyridin-3-yl]acetamide
- [11C]Norepinephrine
- [11C]-p-Hydroxyphenethylguanidine
- [11C]Triphenylmethylphosphonium
- [18F]-3-Fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol
- [1-methyl-11C]8-Dicyclopropylmethyl-1-methyl-3-propylxanthine
- [4-O-methyl-11C]-8-[(E)-2-(3,4-Dimethoxyphenyl)ethenyl]-1,3-diethyl-7-methylpurine-2,6-dione
- [6-O-methyl-11C]Diprenorphine
- [7-methyl-11C]-(E)-8-(3,4,5-Trimethoxystyryl)-1,3,7-trimethylxanthine
- [carbonyl-11C](R,S)-(N-(2-(1-(4-(2-Methoxyphenyl)piperazinyl)(2-methylethyl)))-N-pyridinyl)cyclohexanecarboxamide
- [Carbonyl-11C](S)-3-chloro-4-(4-((2-(pyridine-3-yl)pyrrolidin-1-yl)methyl)phenoxy)benzamide
- [Carbonyl-11C]N-(2-(1-(4-(2-Methoxyphenyl)-piperazinyl)ethyl)-N-pyridinyl)cyclohexanecarboxamide
- [Carbonyl-11C]-N-(4-Fluorobenzyl)-4-(3-(piperidin-1-yl)indole-1-sulfonyl)benzamide
- [N-11C-methyl]-[4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)-2-pyrimidinyl]amino]phenyl]benzamide
- [N-Methyl-11C]-(11β17α)-11-[4-(dimethylamino)phenyl]-17-hydroxy-21-[4-(methylsulfonyl)phenyl]-19-norpregna-4,9-dien-20-yn-3-one
- [N-methyl-11C]4-(4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl)-2,2-diphenyl-N-dimethyl-butanamide
- [N-methyl-11C]4-(4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl)-2,2-diphenyl-N-methyl-butanamide
- [O-11C-methyl]4-N-(3-Bromoanilino)-6,7-dimethoxyquinazoline
- [O-methyl-11C]2-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)dione
- [O-methyl-11C]2-{4-[4-(7-Methoxynaphthalen-1-yl)piperazin-1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione
- [S-methyl-11C]N,N-Dimethyl-4-(6-(methylthio)imidazo[1,2-a]pyridine-2-yl)aniline
- 1-([4-methoxy-11C]-3,4-Dimethoxyphenethyl)-4-(3-phenylpropyl)piperazinephenoxy)
- 1-([4-methoxy-11C]3,4-Dimethoxyphenethyl)-4-[3-(4-fluorophenyl)propyl]piperazine
- 1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid [11C]methyl ester
- 1-(2,4-Dichlorophenyl)-4-cyano-5-(4-[11C]methoxyphenyl)-N-(pyrrolidin-1-yl)-1H-pyrazole-3-carboxamide
- 1-(2-Chlorophenyl)-N-[11C]methyl-N-(1-methylpropyl)-3-isoquinoline carboxamide
- 1-(3,4-[11C]Dimethoxyphenethyl)-4-[3-(3,4-dichlorophenyl)propyl]piperazinephenoxy)
- 1-(3-[11C]Methoxy-4-methoxybenzyl)-6,7-dimethoxyisoquinoline
- 1-(9H-Carbazol-4-yloxy)-3-(2-(2-[11C]methoxyphenoxy)ethylamino)-propan-2-ol
- 1-(Benzofuran-2-ylmethyl)-4-(4-[11C]methoxybenzyl)piperazine
- 1-[11C]Arachidonic acid
- 1-[11C]Methylpiperidin-4-yl propionate
- 1-11C-Methyl-4-piperidinyl n-butyrate
- 11C/68Ga-Labeled sel-tagged anti-epidermal growth factor receptor 2 affibody ZHER2:342
- 11C-Labeled 1,7β,10β-trihydroxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoate}
- 11C-Labeled 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride
- 11C-Labeled GSK931145
- 11C-Labeled isoniazid
- 11C-Labeled pyrazinamide
- 11C-Labeled rhodamine-123
- 11C-Labeled rifampicin
- 11C-Labeled Telmisartan, an angiotensin II type 1 receptor antagonist
- 1R-[11C]Phenylephrine
- 2,2,3,3-Tetramethylcyclopropanecarboxylic acid [3-(2-[11C]methoxyethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]amide
- 2-(2-(3-[11C]Methoxyphenyl)ethynyl)pyridine
- 2-(2-(5-[11C]Methoxypyridin-3-yl)ethynyl)pyridine
- 2-(2-[[O-11C]Tolyl)vinyl]-4,5-dihydro-1H-imidazole
- 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-[11C]methyl-amino]-2-propan-2-yl-pentanenitrile
- 2-(3-Fluoro-[4-11C]tolyl)-4,5-dihydro-1H-imidazole
- 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-[11C]methoxybenzyl)ethanamine
- 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-[11C]methoxybenzyl)ethanamine
- 2-(5-[11C]Methyl-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl)-xanthene-9-one
- 2-(6-[11C]Methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl)-7-(6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl)-9H-fluoren-9-one
- 2-[11C]Methyl-5-[6-phenylpyridazine-3-yl]octahydropyrrolo[3,4-c]pyrrole
- 2-[11C]Methyl-6-(2-phenylethynyl)pyridine
- 2-[2-([O-11C]Tolyl)ethyl]-4,5-dihydro-1H-imidazole
- 2-[methyl-11C]Methoxyestradiol
- 2-Butyl-5-[11C]methoxymethyl-6-(1-oxopyridin-2-yl)-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-3H-imidazo[4,5-b]pyridine
- 2-chloro-N-((S)-((S)-1-[11C]methylpiperidine-2-yl)(thiophen-3-yl)methyl)-3-(trifluoromethyl)benzamide ([11C]SA1) and derivatives
- 2-Hydroxy-3-isobutyl-9-[11C]methoxy-10-methoxy-1,2,3,4,6,7,-hexahydro-11bH-bezo[α]-quinolizine
- 2β-Carbo[11C]methoxy-3β-(3´-((Z)-2-iodoethenyl)phenyl)nortropane
- 2β-Carbo[11C]methoxy-3β-(4´-((Z)-2-iodoethenyl)phenyl)nortropane
- 2’-Fluoro-5-([11C]-methyl)-1-β-D-arabinofuranosyluracil
- 3-(6-Methyl-pyridin-2-ylethynyl)-cyclohex-2-enone-O-11C-methyl-oxime
- 3-[3,5-Dimethyl-4-(4-[11C]methylpiperazinecarbonyl)-1H-pyrrol-2-ylmethylene]-2-oxo-2,3-dihydro-1H-indole-5-sulfonic acid (3-chlorophenyl)methylamide
- 3-Fluoromethyl-N-[11C]methyl-4-phenyl-N-(phenylmethyl)quinoline-2-carboxamide
- 3-N-[11C]Methylspiperone
- 4-(3-Cyclopentoxy-4-[11C]methoxy-phenyl)pyrrolidin-2-one
- 4-[11C]Methylphenyl-1,4-diazabicyclo[3.2.2]nonane-4-carboxylate
- 4-Acetoxy-7-chloro-3-(3-(-4-[11C]methoxybenzyl)phenyl)-2(1H)-quinolone
- 4-Cyano-1-(2,4-dichlorophenyl)-5-(4-[11C]methoxyphenyl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide
- 4-Hydroxy-, 5-hydroxy-, and 7-hydroxy- analogs of 6-hydroxy-2-(4’-[11C]methylaminophenyl)-1,3-benzothiazole
- 5-(6-(5-[11C]methylhexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)pyridazin-3-yl)-1H-indole
- 5-Amino-7-(3-(4-[11C]methoxy)phenylpropyl)-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine
- 5-Methyl-8-(4-[11C]methyl-piperazin-1-yl)-4-oxo-4H-chromene-2-carboxylic acid (4-morpholin-4-yl-phenyl)-amide
- 6,7-Dimethoxy-2-[3-(5-[11C]methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-1,2,3,4-tetrahydro-isoquinoline
- 6,7-Dimethoxy-2-{3-[4-[11C]methoxy-3,4-dihydro-2H-naphthalen-(1E)-ylidene]-propyl}-1,2,3,4-tetrahydro-isoquinoline
- 6-Hydroxy-[1,1'-biphenyl]-3-yl-cyclohexyl-[11C-carbonyl]carbamate
- 7-[ 11C]Methoxy-1-methyl-9H-[3,4-b]indole
- 8-((E)-4-Fluoro-but-2-enyl)-3β-p-tolyl-8-aza-bicyclo[3.2.1]octane-2β-carboxylic acid [11C]methyl ester
- Biphenyl-3-yl-4-[11C]methoxyphenylcarbamate
- Dimethylamino-3(4-[11C]methoxyphenyl)-3H-pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-one
- Ethyl 8-fluoro-5-[11C]methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
- L-[5-11C]-Glutamine
- l-[methyl-11C]Methionine
- Methyl-[11C]-4'-thiothymidine
- N,N-Diethyl-2-2(2-(4-[11C]methoxyphenyl)-5,7-dimethyl-pyrazolo(1,5-a)pyrimidin-3-yl)-acetamide
- N-(2-[11C],5-Dimethoxybenzyl)-N-(5-fluoro-2-phenoxyphenyl)acetamide
- N-(4-(6-(Isopropylamino)pyrimidin-4-yl)-1,3-thiazol-2-yl)-4-[11C]methoxy-N-methylbenzamide
- N-(4-(6-(Isopropylamino)pyrimidin-4-yl)-1,3-thiazol-2-yl)-N-methyl-4-[11C]methylbenzamide
- N-[(1s)-1-[4-[[4-methoxy-2-[(4-[11C]methoxyphenyl)sulfonyl]-phenyl]sulfonyl]phenyl]ethyl]methanesulfonamide
- N-[[4'-[(2-Ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridine-3-yl)methyl][1,1'-biphenyl]-2-yl]sul-fonyl]-4-[11C]methoxybenzamide
- N-[11C]Methyl-3-[[(dimethylamino)carbonyl]oxy]-2-(2’,2’-diphenylpropionoxymethyl)pyridinium
- N-[11C]Methylpiperidin-4-yl acetate
- N-[2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-[11C]methoxybenzamide
- N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-S-[11C]methyl-L-cysteine
- N1’-([11C]Methyl)naltrindole
- N2-{6-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)(methyl)amino]hexyl}-N2-[11C]methyl-2-furamide
- N-4-Fluorobut-2-yn-1-yl-2β-carbo-[11C]methoxy-3β-phenyltropane
- N-Acetyl-N-(2-[11C]methoxybenzyl)-2-phenoxy-5-pyridinamine
- N-Benzyl-N-ethyl -2-(7-[11C]-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide
- N-Methyl-[11C]-2-(4'-methylaminophenyl)-6-hydroxybenzothiasole
- O-[11C]methyl derivative of 6,7-dimethoxy-2-(4-methoxy-biphenyl-4-yl-methyl)-1,2,3,4-tetrahydro-isoquinoline
- R-(−)-[11C]Epinephrine
- S-[11C]Methyl-L-cysteine
- S-4-(3-([11C]Isopropylamino)-2-hydroxypropoxy)-2H-benzimidazol-2-one
- trans-(+)-1,2,3,5,6,10b-Hexahydro-6-(4-([11C]methylthio)-phenyl)pyrrolo-(2,1-a)-isoquinoline
- 124I
- [124I]Iodo-azomycin-galactoside
- 124/131I-Labeled apoptosis-targeting peptide-1 (ApoPep-1)
- 124I/64Cu-Labeled anti-CD20 minibody
- 124I-Annexin V
- 124I-Anti-CD44v6 chimeric monoclonal antibody U36
- 124I-Anti–prostate stem-cell antigen back-mutated 2B3 diabody
- 124I-Anti-PSCA 2B3 minibody
- 124I-Chimeric monoclonal antibody G250
- 124I-Labeled antibody against lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1)
- 124I-Labeled anti-CD20 scFv-sc fragment
- 124I-Labeled anti-HER2-specific C6.5 diabody
- 124I-Labeled anti-prostate stem cell antigen affinity-matured A11 minibody
- 124I-Labeled humanized CH2-domain-deleted anti-tumor-associated glycoprotein-72 (TAG-72) monoclonal antibody
- 124I-Labeled residulizing ligand IMP-R4 conjugated chimeric monoclonal antibody ch806 targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII)
- 2'-Fluoro-2'-deoxy-5'-[123/124/125/131I]iodo-1β-d-arabinofuranosyluracil
- 13N
- 149Tb, 152Tb, 155Tb, 161Tb
- 18F
- (-)-7-Methyl-2-exo-[3'-(6-[18F]fluoropyridin-2-yl)-5'-pyridinyl]-7-azabicyclo[2.2.1]heptane
- (+)-2-Hydroxy-3-isobutyl-9-(3-[18F]fluoropropoxy)-10-methoxy-1,2,3,4,6,7-hexahydro-11bH-benzo[a]quinolizine
- (1R,2S,3S,5S)-Methyl-8-{[(1S,2S)-2-([18F]fluoromethyl)cyclopropyl]methyl}-3-phenyl-8-azabicyclo[3.2.1]octane-2-carboxylate
- (20R)-4,5-α-Epoxy-6-(2-[18F])fluoroethoxy)-3-hydroxy-α,17-dimethyl-α-(2-phenyleth-1-yl)-6,14-ethenomorphinan-7-methanol
- (3R,5R)-5-(3-(2-[18F]Fluoroethoxy)phenyl)-3-((R)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one
- (3R,5R)-5-(3-[18F]Fluoromethoxy-d2)phenyl)-3-((R)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one
- (3R,5R)-5-(3-[18F]Fluoromethoxy-phenyl)-3-((R)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one
- (4S)-4-(3-[18F]Fluoropropyl)-l-glutamate
- (E)-2-(2-(2-(2-[18F]Fluoroethoxy)ethoxy)ethoxy)-5-(4-dimethylaminostyryl)-pyridine
- (E)-3-(4-(Dimethylamino)phenyl)-1-(4-(2-(([18F]fluoroethoxy)ethoxy)ethoxy)phenyl)-2-propen-1-one
- (E)-3-(Pyridin-2-ylethynyl)-cyclohex-2-enone-O-2-(2-[18F]fluoroethoxy)ethyl oxime
- (E)-4-(2-(6-(2-(2-(2-([18F]-fluoroethoxy)ethoxy)ethoxy)pyridin-3-yl)vinyl)-N-methylbenzenamine
- (R,S)-2-(N-Propyl-N-5'-[18F]fluoropentyl)amino-5-hydroxytetralin
- (R,S)-anti-1-Amino-2-[18F]fluorocyclopentyl-1-carboxylic acid
- (R)-2-(N-Benzyl-4-(2-[18F]fluoroethoxy)phenylsulfonamido)-N-hydroxy-3-methylbutanamide
- (R)-2-Amino-3-[18F]fluoro-2-methylpropanoic acid
- (R)-3-[18F]Fluoro-2-methyl-2-N-(methylamino)propanoic acid
- (S,S)-2-(α-(2-[18F]Fluoro[2H2]methoxyphenoxy)phenoxy)benzyl)morpholine
- (S,S)-2-[α-(2-(2-[18F]Fluoro[2H4]ethoxy)phenoxy)benzyl]morpholine
- (S,S)-2-[α-(2-(2-[18F]Fluoroethoxy)phenoxy)benzyl]morpholine
- (S)-1-((1-(2-[18F]Fluoroethyl)-1H-[1,2,3]-triazol-4-yl)methyl)-5-(2-4-difluorophenoxymethyl-pyrrolidine-1-sulfonyl)isatin
- (S)-1-(4-(2-[18F]Fluoroethoxy)benzyl)-5-[1-(2-methoxymethyl-pyrrolidinyl)sulfonyl]-1H-indole-2,3-dione
- (S)-2-Amino-3-[1-(2-[18F]fluoroethyl)-1H-[1,2,3]triazol-4-yl]propanoic acid
- (S)-N-((1-Allyl-2-pyrrolidinyl)methyl)-5-(3-[18F]fluoropropyl)-2,3-dimethoxybenzamide
- (S)-N-((1-Allyl-2-pyrrolidinyl)methyl)-5-(3-[18F]fluoropropyl)-2-methoxybenzamide
- [18F]1-(2-Fluoroethyl)-4-[(4-cyanophenoxy)methyl]piperidine
- [18F]1-(3-Fluoropropyl)-4-[(4-cyanophenoxy)methyl]piperidine
- [18F]-2-(2-Nitroimidazol-1H-yl)-(3,3,3-trifluoropropyl)acetamide
- [18F]3-(1H-Imidazol-4-yl)propyl-4-fluorobenzyl ether
- [18F]3-Fluoro-5-[(2-methyl-1,3-thiazol-4-yl)ethynyl]benzonitrile
- [18F]3-Fluoro-5-[(pyridin-3-yl)ethynyl]benzonitrile
- [18F]-5-(2-fluoroethyl)2,4-diethyl-3-(ethylsulfanylcarbonyl)-6-phenylpyridine-5-carboxylate
- [18F]5-(6-Fluorohexyn-1-yl)-3-[2(S)-2-azetidinylmethoxy]pyridine
- [18F]6-(2-Fluoropropyl)-4-methyl-pyridin-2-amine
- [18F]6-fluoro-3-O-methyl-L-3,4-dihydroxyphenylalanine
- [18F]FB-(Ac-NIe-Asp-His-d-Phe-Arg-Trp-Gly-Lys-NH2)
- [18F]FB-NH-mini-PEG-E{E[c(RGDyK)]2}2
- [18F]Fluoro-[1,2-2H4]choline
- [18F]Fluoro-2-deoxy-2-D-glucose
- [18F]-Fluoro-2-deoxy-d-glucose-folate
- [18F]Fluorobenzaldehyde-leptin
- [18F]Fluorobenzoyl-((VHPKQHRGGSY)2K)2KK
- [18F]Fluorobenzoyl anti-HER2 Cys-diabody
- [18F]Fluorobenzoyl-PEGylated cyclic arginine-glycine-aspartic acid peptide
- [18F]Fluorobenzyl-bombesin[7-14]-c(RGDyK)
- [18F]Fluorobenzyl-PEG3-Glu-c(RGDyK)-bombesin[7-14]
- [18F]Fluorocholine
- [18F]Fluorodipalmitin-labeled liposomes
- [18F]Fluoroerythronitroimidazole
- [18F]Fluoroetanidazole
- [18F]Fluoroethylcholine
- [18F]Fluoroethyl-recombinant human interlukin-1 receptor antagonist
- [18F]Fluoromethyl-d-tyrosine
- [18F]Fluoromisonidazole
- [18F]Fluoropropyl-Tanaproget
- [18F]-Labeled (R)-(2-(2-(2-methylpyrrolidin-1-yl)ethyl)benzofuran-5-yl)(4-fluorophenyl)-methanone
- [18F]N-(2-benzofuranylmethyl)-N'-[4-(2-fluoroethoxy)benzyl]piperazine
- [18F]-N-(2-Chloro-6-methylphenyl)-2-(6-(4-(2-fluoroethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide
- [18F]-N-{4-[(4,5-Dichloro-2-fluorophenyl)amino]quinazoline-6-yl}-dimethylamine-butylamide
- [18F]Norchloro-fluoro-homoepibatidine
- [18F]SB209670
- [18F]Y1-973
- [18F]α/γ-Fluorobenzylamine-folate
- [2-[18F]Fluoromethoxy-5-(5-trifluoromethyl-tetrazol-1-yl)-benzyl]([2S,3S]2-phenyl-piperidin-3-yl)-amine
- 1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-4-((6-[18F]fluoropyridin-3-yl)methyl)piperazine
- 1-(2'-Deoxy-2'-[18F]fluoroarabinofuranosyl)cytosine
- 1-(2'-Deoxy-2'-[18F]fluoro-β-d-arabinofuranosyl)-5-iodocytosine
- 1-(2-[18F]Fluoro-3-pyridyl)-4-(2-isopropyl-1-oxo-isoindoline-5-yl)-5-methyl-1H-1,2,3-triazole
- 1-(2-[18F]Fluoro-3-pyridyl)-4-(2-propyl-1-oxo-isoindoline-5-yl)-5-methyl-1H-1,2,3-triazole
- 1-(2-{(2R)-1-[(2-[18F]Fluorophenyl)sulfonyl]pyrrolidin-2-yl}ethyl)-4-methylpiperidine
- 1-(2’-Deoxy-2’-[18F]-fluoro-β-D-arabinofuranosyl)thymine
- 1-(4-[18F]Fluoroethoxy-3-methoxyphenethyl)-4-(3-phenylpropyl)piperazine
- 1-(4-[18F]Fluoromethoxy-3-methoxyphenethyl)-4-(3-phenylpropyl)piperazine
- 1-(5-[18F]Fluoro-5-deoxy-α-D-arabinofuranosyl)-2-nitroimidazole
- 1-[18F]Fluoro-3,6-dioxatetracosane
- 1-[4-(2-[18F]Fluoroethoxy)-benzyl]-5-(2-phenoxymethyl-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-[4-(3-[18F]Fluoropropoxy)-3-methoxyphenyl]-5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1,4,6-heptatrien-3-one
- 11C-BMS-5p and 18F-FBzBMS: radiolabeled analogs of BMS-207940, a potent and selective antagonist of endothelin receptor subtype A
- 16α-[18F]Fluoro-17β-estradiol
- 18-[18F]Fluoro-4-thia-oleate
- 18-[18F]Fluoro-4-thia-palmitate
- 18F-(2S,4R)4-fluoroglutamine
- 18F-1,4,7-Triazacyclononane-1,4,7-triacetic acid-10-maleimidoethylacetamide-Affibody ZHER2:2395
- 18F-6-Fluoro-N-[2-(diethylamino)ethyl]pyridine-3-carboxamide
- 18F-Fluoroethyl triazole-βAG-[(d)-Phe1-c(Cys2-Tyr3-(d)-Trp4-Lys5-Thr6-Cys7)Thr8]
- 18F-Labeled 4-(5-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)benzofuran-2-yl)-N,N-dimethylbenzenamine
- 18F-Labeled 5-(5-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)benzofuran-2-yl)-N,N-dimethylpyridin-2-amine
- 18F-Labeled 6-amino-2-(4’-fluorophenyl)-1,3-benzothiazole and other derivatives
- 18F-Labeled 6-methyl-2-(4’-fluorophenyl)-1,3-benzothiazole
- 18F-Labeled Cys-ZHER2:342, an anti-epidermal growth factor receptor-2 Affibody
- 18F-Labeled exendin(9-39)
- 18F-Labeled fluoropegylated 6-fluoroethoxy-4'-dimethylaminoflavone, 6-(2-(2-fluoro-ethoxy)-ethoxy)-4'-dimethylaminoflavone, and 6-(2-(2-(2-fluoro-ethoxy)-ethoxy)ethoxy)-4'-dimethylaminoflavone
- 18F-Labeled N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2-(2-[18F]-fluoroethoxy)-5-iodo-3-methoxybenzamide
- 18F-Labeled N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2-(2-fluoroethoxy)-5-methylbenzamide
- 18F-Labeled N-(4-fluorobenzylidene)oxime-dimeric (ZHER2:477)2
- 18F-Labeled N-(4-fluorobenzylidene)oxime-monomeric ZHER2:477
- 18F-Labeled N-(4-fluorobenzylidene)oxime-VENK[homoC]NKEMRNRYWEAALDPNLNNQQKRAKIRSIYDDP[homoC]-NH2 with a disulfide bridge between the two homoC
- 18F-Labeled neogalactosylalbumin
- 18F-Labeled N-succinimidyl-4-fluorobenzoate–conjugated rat anti-mouse vascular endothelial growth factor receptor 2 monoclonal antibody linked to microbubbles
- 18F-Labeled poly(L-lactic acid)-block-poly(sarcosine) lactosome, a polymer micelle
- 18F-Tetrazine-trans-cyclooctene-Cys40-exendin-4
- 1-Deoxy-1-[18F]fluoro-scyllo-inositol
- 1-O-(4-(2-[18F]Fluoroethyl-carbamoyloxymethyl)-2-nitrophenyl)-O-β-d-glucopyronuronate
- 2´-Deoxy-2´-[18F]fluoro-5-fluoro-1-β-D-arabinofuranosyluracil
- 2'-Deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl-adenine
- 2-((2-Amino-4-chloro-5-[18F]fluorophenyl)thio)-N,N-dimethylbenzenmethanamine
- 2-(+/-)-2-exo-(2'-[18F]Fluoro-3'-phenyl-pyridin-5'-yl)-7-azabicyclo[2.2.1]heptane
- 2-(1-{6-[(2-[18F]Fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile
- 2-(2'-((Dimethylamino)methyl)-4'-(3-[18F]fluoropropoxy)-phenylthio)benzenamine
- 2-(2-(2-(4-((4-(Methylamino)phenyl)ethynyl)phenoxy)ethoxy)[18F]fluoroethoxy)ethyl-4-methylbenzenamine
- 2-(2-Nitro-1H-imidazol-1-yl)ethyl 2-[18F]fluoroacetate
- 2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-[18F]pentafluoropropyl)-acetamide
- 2-(2-Nitroimidazol-1H-yl)-(3-[18F]fluoropropyl)acetamide
- 2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid
- 2-(4-(2-[18F]Fluoroethyl)piperidin-1-yl)benzo[4,5]imidazo[1,2-a]pyrimidine
- 2-(4-(4-[18F]Fluoro-butyl)-benzylsulfanyl)-3-methyl-chromen-4-one
- 2-(4-Aminophenyl)-6-(2-([18F]fluoroethoxy))quinoline
- 2-(5-[18F]Fluoro-pentyl)-2-methyl-malonic acid (ML-10)
- 2-(6-Chloro-2-(4-(3-[18F]fluoropropoxy)phenyl)imidazo[1,2-a]pyridin-3-yl)-N,N-diethylacetamide
- 2-[(2-chloro-2’-18F-fluorodiethyl)amino]-2H-1,3,2-oxazaphosphorinane-2-oxide
- 2-[(4-{[(2-amino-4-oxohydropteridin-7yl)methyl]amino}phenyl) carbonylamino]-4-{N-[(2-[18F]-fluoro(4-pyridyl))carbonylamino] carbamoyl}butanoic acid
- 2-[(4-{[(2-amino-4-oxohydropteridin-7yl)methyl]amino}phenyl) carbonylamino]-4-{N-[(4-[18F]-fluorophenyl)carbonylamino] carbamoyl}butanoic acid
- 2-[18F]Fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine
- 2-[18F]Fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine
- 2-[18F]Fluoroacetate
- 2-[18F]Fluoro-N-(2-(2-nitro-1H-imidazol-1-yl)ethyl)acetamide
- 2-[18F]Fluoropropionyl-osteosarcoma–specific peptide-1 (ASGALSPSRLDT)
- 2-[18F]Fluoropyridine-4-carbohydrazide-methotrexate
- 2-[4-(4-[18F]Fluorobutyl)benzylsulfanyl]-3-methylchromene-4-one
- 2-{3-[18F]Fluoro-4-(methylamino)phenyl}-1,3-benzothiazol-6-ol
- 2-{4-[-Pyridin-4-yl-1-(2-[18F]fluoro-ethyl)-1H-pyrazol-3-yl]-phenoxymethyl}-quinoline
- 2-Deoxy-2-[18F]fluorosorbitol
- 2-tert-Butyl-4-chloro-5-[4-(2-[18F]fluoroethoxymethyl)-benzyloxy]-2H-pyridazin-3-one
- 2-tert-Butyl-4-chloro-5-[4-(2-[18F]fluoro-ethoxymethyl)-benzyloxy]-3-(2H)-pyridazinone
- 2-tert-Butyl-4-chloro-5-[4-(4-[18F]fluoro-butyl)-benzyloxy]-2H-pyridazin-3-one
- 2β-Carbo(2-[18F]fluoroethoxy)-3β-(3´-((Z)-2-iodoethenyl)phenyl)nortropane
- 2β-Carbo(2-[18F]fluoroethoxy)-3β-(4´-((Z)-2-iodoethenyl)phenyl)nortropane
- 2β-Carbomethoxy-3β-(4-chlorophenyl)-8-(2-[18F]fluoroethyl)nortropane
- 2’-[18F]Fluoroflumazenil
- 2’-[18F]Fluorofolic acid
- 3'-Aza-2'-[18F]fluorofolic acid
- 3'-Deoxy-3'-[18F]fluoro-1-β-D-xylofuranosyl-adenine
- 3'-Deoxy-3'-[18F]fluorothymidine
- 3-(2-(S)-3,4-Dehydropyrrolinyl methoxy)-5-(3'-[18F]fluoropropyl)pyridine
- 3-(3-(3-[18F]Flouropropyl)thio)-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine
- 3-(4-[18F]Fluorobenzyl)-8-methoxy-1,2,3,4 tetrahydrochromeno[3,4-c]pyridin-5-one
- 3-(Pyridin-2-ylethynyl)-cyclohex-2-enone-O-[18F]fluoroethyl-oxime
- 3-[2-[4-(4-[18F]Fluorobenzoyl)-1-piperidyl]ethyl]-2-sulfanyl-3H-quinazolin-4-one
- 3-{4-[2-[Benzoxazol-2-yl-methylamino]ethoxy]phenyl}-2-(2-[18F]fluoroethoxy)propionic acid
- 3-Chloro-4-[18F]fluorophenyl-(4-fluoro-4-[[((5-methyl-4-methylamino-pyridin-2-ylmethyl)-amino]-methyl]-piperidin-1-yl)methanone (F13714)
- 3-Chloro-4-[18F]fluorophenyl-(4-fluoro-4-[[(5-methyl-pyrimidin-2-ylmethyl)-amino]-methyl]-piperidin-1-yl)methanone (F15599)
- 3-Cyano-4-[18F]fluoro-benzoyl-Ala(SO3H)-Ala(SO3H)-Ava-Gln-Trp-Ala-Val-NMeGly-His-Sta-Leu-NH2
- 3-Cyano-4-[18F]fluoro-benzoyl-Ala(SO3H)-Ava-Gln-Trp-Ala-Val-NMeGly-His-Sta-Leu-NH2
- 3-Cyano-4-[18F]fluoro-benzoyl-Arg-Ava-Gln-Trp-Ala-Val-NMeGly-His-Sta-Leu-NH2
- 3-N-(2-[18F]Fluoroethyl)spiperone
- 3-β-(4-Iodophenyl)tropane-2-β-carboxylic acid 2-[18F]fluoroethyl ester
- 4,16α-[16α-18F]Difluoro-11β-methoxyestradiol
- 4-(2´-Methoxyphenyl)-1-[2´-(N-2´´-1,3 pyrimidino)-p-[18F]fluorobenzamido]ethylpiperazine
- 4-(2´-Methoxyphenyl)-1-[2´-(N-2´´-pyridinyl)-p-[18F]fluorobenzamido]ethylpiperazine
- 4-(2-(4-(4-[18F]Fluoro-butyl)-phenyl)ethoxy) quinazoline
- 4-(3-((5-(2-[18F]Fluoroethoxy)pyridine-2-yl)oxy)benzylidene)-N-(pyridazin-3-yl)piperidine-1-carboxamide
- 4-[18F]Fluoro-2-D-methyl-3-mercaptopropanoyl-L-proline
- 4-[18F]Fluorobenzenecarbohydrazide-methotrexate
- 4-[18F]Fluorobenzoyl-annexin V
- 4-[18F]Fluorobenzoyl-Arg-Arg-Natl-Cys-Tyr-Cit-Lys-d-Lys-Pro-Tyr-Arg-Cit-Cys-Arg-NH2
- 4-[18F]Fluorobenzoyl-C2A domain of synaptotagmin I-glutathione-S-transferase
- 4-[18F]Fluorobenzoyl-endothelin-1
- 4-[18F]Fluorobenzoyl-knottin 2.5D
- 4-[18F]Fluorobenzoyl-NAVPNLRGDLQVLAQKVART
- 4-[18F]Fluorobenzoyl-Phe-Ala-Leu-Gly-Glu-Ala-NH2
- 4-[18F]Fluorobenzoyl-rhenium-cyclized-Ac-D-Lys-[Cys3,4,10, D-Phe7, Arg11]α-MSH3-13
- 4-[18F]Fluorobenzoyl-T84.66 diabody
- 4-[18F]Fluorobenzoyl-ε-Lys1-c(KRGDe)MDDPGRNPHhCitGPAT
- 4-[18F]Fluorobenzyl-triphenylphosphonium
- 4-[18F]Fluoro-l-m-tyrosine
- 4-[18F]Fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide
- 4-[18F]Fluoropaclitaxel
- 4-[5-(4-[18F]Fluoro-phenyl)-[1,3,4]oxadiazol-2-yl]-1,4-diaza-bicyclo[3.2.2]nonane
- 4-Bromo-1-(3-[18F]fluoropropyl)-2-nitroimidazole
- 5-(2-[18F]Fluoroethoxy)-L-tryphan
- 5-(5-(2-(2-(2-[18F]Fluoroethoxy)ethoxy)ethoxy)benzofuran-2-yl)-N-methylbenzenamine
- 5-(5-(2-(2-(2-[18F]Fluoroethoxy)ethoxy)ethoxy)benzofuran-2-yl)-N-methylpyridin-2-amine
- 5-[(E)-2-(4-[18F]Fluorophenyl)ethenyl]-1,3-benzenediol
- 5-[18F]Fluoro-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-oxazolo[5,4-b]pyridine
- 5-3’-[18F]Fluoropropyl-3-[2-((S)-pyrrolidinyl)methoxy]pyridine
- 6-(2-[18F]Fluoroethoxy)-2-[2-(4-methylaminophenyl)ethenyl]benzoxazole
- 6-(3'-[18F]Fluoropropyl)-2-(4'-dimethylamino)phenylimidazol[1,2-α]pyridine
- 6-[1-(2-[18F]Fluoro-3-pyridyl)-5-methyl-1H-1,2,3-triazol-4-yl]quinoline
- 6-[18F]Fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine
- 6-[18F]Fluorodopamine
- 6-[18F]Fluoro-l-m-tyrosine
- 6-Deoxy-6-[18F]fluoro-D-fructose
- 6-Iodo-2-[4'-N-(2-[18F]fluoroethyl)methylamino]phenylimidazo[1,2-a]pyridine
- 6-O-(2-[18F]Fluoroethyl)-6-O-desmethyldiprenorphine
- 8-Cyclopentyl-3-(3-[18F]fluoropropyl)-1-propylxanthine
- 9-(4-(2-[18F]Fluoroethyl)benzyl)-9-azabicyclo[3.3.1]nonan-3-yl-2-methoxy-5-methyl-phenylcarbamate
- 9-(4-[18F]Fluoro-3-hydroxymethylbutyl)guanine
- Ad5-(PSE-BC)-(GAL4-(VP16)2)-(GAL4)5-sr39tk
- Al18F-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-Glu-[cyclo(Arg-Gly-Asp-d-Phe-Lys)]2
- Al18F-1,4,7-Triazacyclononane-1,4,7-diacetic acid-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
- anti-1-Amino-2-[18F]fluorocyclobutane-1-carboxylic acid
- anti-1-Amino-3-[18F]fluorocyclobutane-1-carboxylic acid
- CtPyPyIm-(R)H2Nγ-PyImPyPy-C3-18F
- Cyclo(-Arg-Gly-Asp-d-Phe-Lys(([18F]Fluoropropionyl)galacto-amino acid)-)
- Cys-Arg-Pro-Pro-Arg-[18F]fluorodipalmitin-liposomes
- Fluoro-pegylated (1E,4E)-1-(4-(dimethylamino)phenyl)-5-(4-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)phenyl)penta-1,4-dien-3-one and (1E,4E)-1-(4-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)phenyl)-5-(4-(methylamino)phenyl)penta-1,4-dien-3-one
- ImPyβImPyβImβ-C3-18F
- L-3,4-Dihydroxy-6-[18F]fluorophenylalanine
- L- and D-S-(3-[18F]fluoropropyl)homocysteine
- m-Cyano-p-[18F]fluorohippurate
- Methyl 2-(2-[18F]fluoro-4-nitrobenzamido)-3-methylbutanoate
- Methyl 2-(2-[18F]fluoro-4-nitrobenzamido)-3- methylbutanoic acid
- Methyl ester of 1-O-(4-(2-[18F]fluoroethyl-carbamoyloxymethyl)-2-nitrophenyl)-O-β-d-glucopyronuronate
- N-((E)-4-[18F]Fluorobut-2-en-1-yl)-2β-carbomethoxy-3β-(4'-fluorophenyl)nortropane
- N-(2-(1-(4-(2-Methoxyphenyl)piperazinyl)ethyl))-N-(2-(6-[18F]fluoro)-pyridinyl)cyclohexanecarboxamide
- N-(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)-4-[18F]-fluorobenzamide ([18F]FBEM) conjugated to EM3106B, an analog of glucagon-like peptide-1
- N-(2-(Diethylamino)ethyl)-6-[18F]fluoronicotinamide
- N-(2-Diethylaminoethyl)-4-[18F]fluorobenzamide for imaging melanoma
- N-(3-[18F]Fluoropropyl)-2β-carbomethoxy-3β-(4-iodophenyl)nortropane
- N-(4-(4-(2-(2-[18F]Fluoroethoxy)phenyl)piperazine-1-yl)butyl)-4-(3-thienyl)benzamide
- N-(4-[18F]Fluoro-benzoyl)-N'-{2-[5-(4-fluoro-benzyl)-1-(4-methoxy-benzyl)-4,6-dioxo-1,4,5,6-tetrahydro-[1,3,5]triazin-2-ylamino]-ethyl}-guanidine
- N-(4-[18F]Fluorobenzyl)-4-(3-(piperidin-1-yl)indole-1-sulfonyl)benzamide
- N-(5-Fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide
- N-(6-[18F]Fluoro-4-phenoxypyridin-3-yl)-N-(2-methoxybenzyl)acetamide
- N-[18F]Fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline
- N-[18F]Fluoroethylpiperidin-4ylmethyl acetate
- N-[2-(3-cyanophenyl)-3-(4-(2-[18F]fluorethoxy)phenyl)-1-methylpropyl]-2-(5-methyl-2-pyridyloxy)-2-methylproponamide
- N-[2-(4-[18F]Fluorobenzamido)ethyl]maleimide-Cys-ZEGFR:1907
- N-[2-(4-[18F]Fluorobenzamido)ethyl]maleimide-sulfhydryl-cyclic-arginine-glycine-aspartic acid dimeric peptide
- N-[2-(4-[18F]Fluorobenzamido)ethyl]maleimide-sulfhydryl-cyclic-arginine-glycine-aspartic acid peptide
- N-[2-[N-Ethyl-N-[2-(2-[18F]fluoropyridin-3-yloxy)ethyl]amino]ethyl]-6-iodoquinoxaline-2-carboxamide
- N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine
- N-{2-[4-(2-Methoxyphenyl)piperazinyl]ethyl}-N-(2-pyridyl)-N-(4-[18F]-fluoromethylcyclohexane)carboxamide
- N-2-(4-[18F]-Fluorobenzamido)ethylmaleimide coupled to cysteine-tagged epidermal growth factor
- N-2-(4-[18F]-Fluorobenzamido)ethylmaleimide coupled to cysteine-tagged on the C- or N-terminal of exendin-4
- N-4'-[18F]Fluorobenzylpiperidin-4yl-(2-fluorophenyl)acetamide
- N-4-[18F]Fluorobenzoyl-c(RGDyK)
- N-4-[18F]Fluorobenzoyl-c[(RGDyK)]2
- N-4-[18F]Fluorobut-2-yn-1-yl-2β-carbomethoxy-3β-phenyltropane
- N-Acetyl-N-(2-[18F]fluoroethoxybenzyl)-2-phenoxy-5-pyridinamine
- N-Benzyl-N-ethyl-2-[7,8-dihydro-7-(2-[18F]fluoroethyl)-8-oxo-2-phenyl-9H-purin-9-yl]acetamide
- N-Benzyl-N-methyl-2-[7,8-dihydro-7-(2-[18F]fluoroethyl)-8-oxo-2-phenyl-9H-purin-9-yl]acetamide
- O-(2-[18F]Fluoroethyl)-L-tyrosine
- O-(3-[18F]Fluoropropyl)-L-tyrosine
- p-(2-[18F]Fluoroethyl)-l-phenylalanine
- P2,P3-[18F]Monofluoromethylene diadenosine-5’,5’’’-P1,P4-tetraphosphate
- Para-[18F]-fluorohippurate
- PEGylated 4-[18F]fluorobenzoyl-NAVPNLRGDLQVLAQKVART
- Polyethylene glycol-Cys-Arg-Ser-Gly-Pro-Leu-Gly-Val-Tyr-[18F]fluorobenzoyl-Lys-Lys-tetramethylrhodamine
- syn-1-Amino-3-[18F]fluorocyclobutane-1-carboxylic acid
- Trans-1,2,3,5,6,10b-hexahydro-6-[4-([18F]fluoroethylthio)-phenyl]pyrrolo-[2,1-a]-isoquinoline
- Trans-4-(N-Methylamino)-4´-{2-[2-(2-[18F]fluoro-ethoxy)-ethoxy]-ethoxy}-stilbene
- 44Sc
- 60,61,62,64, 67Cu
- 64Cu
- [64Cu](1-N-(4-aminobenzyl)-3,6,10,13,16,19-hexaazabicyclo[6.6.6]-eicosane-1,8-diamine)-anti-GD2 monoclonal antibody
- [64Cu]-1,4,7,10-Tetra-azacyclododecane-N,N’,N’’,N’’’-tetraacetic acid conjugated knottin 2.5D
- [64Cu]-1,4,7,10-Tetra-azacyclododecane-N,N’,N’’,N’’’-tetraacetic acid conjugated knottin 2.5F
- 64Cu-[Ac-NIe-Asp-His-d-Phe-Arg-Trp-Gly-Lys(1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid)-NH2]
- 64Cu-[cinnamoyl-Phe-D-Leu-Phe-D-Leu-Phe-Lys(PEG-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid)-NH2]
- 64Cu-{N-[1,4,8,11-Tetraazacyclotetradecanyl-1,4-phenylenebis(methylene)]-2-(aminomethyl)pyridine}
- 64Cu-1,4,7,10-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13
- 64Cu-1,4,7,10-Tetraazacyclodecane-N,N',N'',N'''-tetraacetic acid-vascular endothelial growth factor
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-anti-CD105 TRC105 chimeric monoclonal antibody
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Arg-Arg-Natl-Cys-Tyr-Cit-Lys-d-Lys-Pro-Tyr-Arg-Cit-Cys-Arg-NH2
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Arg-rich Cys knot scaffold grafted with integrin αvβ6-binding peptide RSLARTDLDHLRGR
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Arg-rich Cys knot scaffold grafted with integrin αvβ6-binding peptide RSLARTDLDHLRGR
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Asp-Gly-Glu-Ala
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-cyclo(CGNSNPKSC)
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-epidermal growth factor receptor-binding fibronectin domain E13.4.3'
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Ser-rich Cys knot scaffold grafted with integrin αvβ6-binding peptide RSLARTDLDHLRGR
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid-(Gly-Ser-Gly)-Lys-Cys-Cys-Tyr-Ser-Leu
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid-human serum albumin-Ac-Cys-ZEGFR:1907
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-tris-acetic acid-10-maleimidethylacetamide-Ac-Cys-ZEGFR:1907
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-Tris-acetic acid-10-maleimidoethylacetamide-ACEQNPIYWARYADWLFTTPLLLLDLALLVDADEGTG
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-β max tris(acetic acid)-10-acetate mono(N-ethylmaleimide amide)-dimeric (ZHER2:477)2
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-β max tris(acetic acid)-10-acetate mono(N-ethylmaleimide amide)-monomeric ZHER2:477
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-anti-prostate-specific membrane antigen 3/A12 monoclonal antibody
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Asp-cyclohexylalanine-Phe-D-Ser-D-Arg-Tyr-Leu-Trp-Ser
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Asp-cyclohexylalanine-Phe-d-Ser-d-Arg-Tyr-Leu-Trp-Ser-NH2 (AE105-NH2)
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-cetuximab
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-C-type atrial natriuretic factor
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid- cyclic arginine-glycine-aspartic acid peptide
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-E(E{E[c(RGDyK)]2}2)2 peptide
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-E{E[c(RGDfK)]2}2
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-E{E[c(RGDyK)]2}2
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-HB22.7
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-interleukin-18-binding protein-Fc
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-panitumumab
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-p-benzyl-NH-hu14.18K322A
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-PEGylated cyclic arginine-glycine-aspartic acid peptide
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-PEGylated dimeric cyclic arginine-glycine-aspartic acid peptide
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-polyethylene glycol 12 anti–tumor-associated glycoprotein 72 diabody
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-polyethylene glycol 27 anti–tumor-associated glycoprotein 72 diabody
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-polyethylene glycol-single-chain Cys-tagged vascular endothelial growth factor-121
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-polyethylene-glycol-single-walled nanotube-c(RGDyK)
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-T84.66 scFv-human serum albumin
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-vascular endothelial growth factor-121(D63AE64AE67A)
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-1,4,7,10-tetraacetic acid-rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid agouti-related protein-7C
- 64Cu-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-cyclo(Arg-Gly-Asp-d-Phe-Lys)
- 64Cu-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-cyclo(Arg-Gly-Asp-d-Tyr-Lys)
- 64Cu-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2
- 64Cu-1,4,7-Triazacyclononane-1,4,7-triacetic acid-Arg-Arg-Natl-Cys-Tyr-Cit-Lys-d-Lys-Pro-Tyr-Arg-Cit-Cys-Arg-NH2
- 64Cu-1,4,7-Triazacyclononane-1,4,7-triacetic acid-p-isothiocyanatobenzyl-ALT-836
- 64Cu-1,4,7-Triazacyclononane-1,4-7-triacetic acid-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
- 64Cu-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-c(RGDyK)-bombesin[7-14]
- 64Cu-1,4,7-Triazacyclononane-1,4-diacetate-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
- 64Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-(Gly-Ser-Gly)-Lys-Cys-Cys-Tyr-Ser-Leu
- 64Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-6-aminohexanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
- 64Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-9-aminonanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
- 64Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-c(RGDyK)-Glu-6-aminohexanoic acid-bombesin[7-14]NH2
- 64Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-para-aminobenzoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
- 64Cu-1,4,8,11-Tetraazacyclotetradecane-N,N',N",N"'-tetraacetic acid-D-Phe-cyclo(Cys-Tyr-D-Trp-Lys-Thr-Cys)-Thr(OH)
- 64Cu-1,4,8,11-Tetraazacyclotetradecane-regioselectively addressable functionalized template-[cyclo-(Arg-Gly-Asp-d-Phe-Lys)]4
- 64Cu-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-cyclic-arginine-glycine-aspartic acid peptide
- 64Cu-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-D-Phe-cyclo(Cys-Tyr-D-Trp-Lys-Thr-Cys)-Thr(OH)
- 64Cu-4,11-bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-LLP2A
- 64Cu-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2
- 64Cu-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-Phe(4-NO2)-cyclo(D-Cys-Tyr-D-Trp-Lys-Thr-Cys)-D-Tyr-NH2
- 64Cu-Anti-human integrin αvβ3 monoclonal antibody
- 64Cu-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-(Gly-Ser-Gly)-Lys-Cys-Cys-Tyr-Ser-Leu
- 64Cu-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-cyclo(Arg-Gly-Asp-d-Phe-Lys)
- 64Cu-Diethylenetriamine pentaacetic acid-NH-CO-CH2-S-CH2-Phe-Pro-Arg-CH2-prothrombin
- 64Cu-DOTA-[Pro1,Tyr4]-Bombesin[1-14]
- 64Cu-DOTA hu4D5v8 (scFv-CH2-CH3)2
- 64Cu-Labeled, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-chelated, and cysteine-modified anti-activated leukocyte cell adhesion molecule diabody
- 64Cu-Labeled 1,1’-{1,4-phenylenebis(methylene)}-bis{1,4,8,11-tetraaza-cyclotetradecane}
- 64Cu-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-VENK[homoC]NKEMRNRYWEAALDPNLNNQQKRAKIRSIYDDP[homoC]-NH2 with a disulfide bridge between the two homoC
- 64Cu-Labeled 1,4,7,10-Tetraazacyclododedane-N,N’,N’’,N’’’-tetraacetic acid–conjugated vascular endothelial growth factor A isoform 121-gelonin fusion protein
- 64Cu-Labeled 1,4,7-tris(acetic acid)-10-vinylsulfone-1,4,7,10-tetraazacyclododecane conjugated to Cys40-Exendin-4
- 64Cu-Labeled 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo [6.6.6] icosane-1-ylamino)methyl)benzoic acid (AmBaSar)
- 64Cu-Labeled 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo [6.6.6] icosane-1-ylamino)methyl)benzoic acid (AmBaSar) conjugated to cyclic arginine-glycine-aspartic acid (RGD) peptide
- 64Cu-Labeled anti-c-kit monoclonal antibody 12A8 Fab fragment
- 64Cu-Labeled bis-1,4,7,10-tetraazacyclododecane-N,N',N,N'-tetraacetic acid conjugated hypericin
- 64Cu-Labeled cysteine–tagged dimeric epidermal growth factor
- 64Cu-Labeled cysteine–tagged epidermal growth factor
- 64Cu-Labeled DOTA conjugated anti-epithelial membrane protein 2 minibody KS83
- 64Cu-Labeled DOTA-conjugated rituximab, a chimeric murine/human anti-CD20 monoclonal antibody
- 64Cu-Labeled human serum albumin–conjugated Affibody ZHER2:342 that targets the human epidermal growth factor receptor 2 (HER2)
- 64Cu-Labeled l-histidine
- 64Cu-Labeled Lys40(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid)NH2–conjugated exendin-4
- 64Cu-Labeled Oxo-DO3A-conjugated trastuzumab and PCTA-conjugated trastuzumab
- 64Cu-Labeled PEGylated nano-graphene oxide (GO) covalently linked to NOTA-conjugated anti-CD105 (endoglin) chimeric monoclonal antibody TRC105
- 64Cu-N,N'-Bis(S-benzoyl-thioglycoloyl)diaminopropanoate-KRAS-PNA-d(Cys-Ser-Lys-Cys)
- 64Cu-Polyethylenimine
- 64Cu-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-conatumumab
- 64Cu-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-MEDI-522
- 64Cu-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-TNYLFSPNGPIARAW (TNYL-RAW)
- 64Cu-Z-E-(1,8-Diamino-3,6,10,13,16,19-hexaazabicyclo(6,6,6)eicosane)-aminohexanoyl-Asp-Gly-Glu-Ala
- Copper 1,4,8,11-tetraazacyclotetradecane-N,N',N'',N'''-tetraacetic acid-octreotide
- HSDAVFTDNYTKLRKQ-NIe-AVKK-(3-OCH3,4-OH)-FLNSSV-GABA-L-(Dap-(BMA)2)-64Cu
- NR-LU-10/streptavidin-copper 64-(1,4,7,10-tetraazacyclododecane-N,N′,N′′,N′′′-tetraacetic acid)-biotin
- 66Ga
- 68Ga
- 67/68Ga-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-1,2-diaminoethane-γ-folate
- 68Ga-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Cpa-cyclo(d-Cys-amino-Phe-hydroorotic acid-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)-D-Tyr-NH2 (JR11)
- 68Ga-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-aminohexanoic acid-Lys40-exendin-4
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-cyclo(Arg-Gly-Asp-D-Phe-Lys)
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Epidermal growth factor
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Gly-Gly-Gly-Gly-Lys-Gly-Gly-Gly-Gly
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-HER2-specific Affibody ZHER2:2891
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Lys40-exendin-3
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-synthetic HER2 specific Affibody ZHER2:342-pep2
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-1,4,7,10-tetraacetic acid-rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13
- 68Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-1,2-diaminoethane-γ-5,8-dideazfolic acid (P3238)
- 68Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-1,2-diaminoethane-γ-folate (P3246)
- 68Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-Asp-cyclohexylalanine-Phe-d-Ser-d-Arg-Tyr-Leu-Trp-Ser-NH2 (AE105-NH2)
- 68Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-Cpa-cyclo(d-Cys-amino-Phe-hydroorotic acid-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)-D-Tyr-NH2 (JR11)
- 68Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-cyclo(Arg-Gly-Asp-d-Phe-Lys)
- 68Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2
- 68Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-2-nitroimidazole-N-ethylamine
- 68Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-c(RGDfK)-human serum albumin-tissue inhibitor of matrix metalloproteinase 2 fusion protein
- 68Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-c(RGDyK)-S-S-CPLHSpT
- 68Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-p-isothiocyanatobenzyl-vascular endothelial growth factor-121
- 68Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-polyethylene glycol-single-chain Cys-tagged vascular endothelial growth factor-121
- 68Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-[15-amino-4,7,10,13-tetraoxapentadecanoic acid-c(Arg-Gly-Asp-D-Phe-Lys)]2
- 68Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-[c(Arg-Gly-Asp-D-Tyr-Lys)]2
- 68Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-[Gly-Gly-Gly-c(Arg-Gly-Asp-D-Phe-Lys)]2
- 68Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-c(RGDyK)-bombesin[7-14]
- 68Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-isothiocyanatobenzyl-c(Arg-Gly-Asp-d-Tyr-Lys)
- 68Ga-1,4,7-Triazacyclononane-1,4-diacetic acid-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
- 68Ga-CHX-A”-Rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13
- 68Ga-Desferrioxamine p-isothiocyanatobenzyl-anti-EGFR nanobody 7D12
- 68Ga-DOTA-4-amino-1-carboxymethyl-piperidine-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2
- 68Ga-Glutamate peptide-3 aminoethyl estradiol
- 68Ga-Isothiocyanatobenzyl-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-2-(2-nitroimidazolyl)ethylamine
- 68Ga-Labeled (1,4,7,10-tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid)-1-NaI3-octreotide
- 68Ga-Labeled (4-{[(bis(phosphonomethyl))carbamoyl]methyl}-7,10-bis(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl)acetic acid (BPAMD)
- 68Ga-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-Tyr-cyclo(DAB-Arg-cyclo(Cys-Phe-d-Trp-Lys-Thr-Cys))
- 68Ga-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-VENK[homoC]NKEMRNRYWEAALDPNLNNQQKRAKIRSIYDDP[homoC]-NH2 with a disulfide bridge between the two homoC
- 68Ga-Labeled 2-[3-(1-carboxy-5-{7-[5-carboxy-5-(3-phenyl-2-{3-phenyl-2-[2-(4,7,10-tris-carboxymethyl-1,4,7,10-tetraazacyclododec-1-l)acetylamino]propionylamino}propionylamino)pentylcarbamoyl]heptanoylamino}pentyl)ureido]pentanedioic acid
- 68Ga-Labeled 2-[4,7-di(carboxymethyl)-1,4,7-triazonan-1-yl]-5-[(4-hydroxy-4,4-diphosphonobutyl)amino]-5-oxopentanoic acid (NOTA-bisphosphonate (BP))
- 68Ga-Labeled 2-{3-[5-(7-{1-benzyloxycarbonyl-5-[2-(4,7,10-tris-carboxymethyl-1,4,7,10-tetraazacyclododec-1-l)acetylamino]pentylcarbamoyl}-heptanoylamino)-1-carboxypentyl]ureido}pentanedioic acid
- 68Ga-Labeled alanine derivatives of 1,4,7,10-tetraazacyclododecane-1,7-diacetic acid and 1,4,7,10-tetraazacyclododecane-1,4,7,-triacetic acid
- 68Ga-Labeled anti-EpCAM diabody against epithelial cell adhesion molecule
- 68Ga-Labeled DOTA-conjugated sCCK8[Phe2(p-CH2SO3H),Nle3,6], a sulfated cholecystokinin 8 (sCCK8) peptide derivative
- 68Ga-Labeled homoalanine derivatives of 1,4,7,10-tetraazacyclododecane-1,7-diacetic acid and 1,4,7,10-tetraazacyclododecane-1,4,7,-triacetic acid
- 68Ga-Labeled NODAGA-conjugated ghrelin receptor agonists and inverse agonists
- 68Ga-Labeled β-aminoalanine, γ-aminohomoalanine, and ε-aminolysine conjugates of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
- 68Ga-Labeled β-aminoalanine, γ-aminohomoalanine, and ε-aminolysine conjugates of 1,4,7-triazacyclononane-1,4,7-triacetic acid
- 68Ga-N,N’-bis[2-Hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N’-diacetic acid-polyethylene glycol-single-chain Cys-tagged vascular endothelial growth factor-121
- 68Ga-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-2-(2-nitroimidazolyl)ethylamine
- 68Ga-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Glu-[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2
- 68Ga-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Glu-{Glu-[cyclo(Arg-Gly-Asp-d-Phe-Lys)]2}2
- 68Ga-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Glu-cyclo(Arg-Gly-Asp-D-Phe-Lys)
- 68Ga-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-d-Glu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2
- 68Ga-Trastuzumab F(ab’) fragment
- Gallium-68-dotamaleimide-Cys165-annexin A5
- Gallium-68-dotamaleimide-Cys2-annexin A5
- Gly-Ala-Cys-Leu-Arg-Ser-Gly-Arg-Gly-Cys-Gly-(PEG)3-DOTA-68Ga
- 74As
- 76Br
- 86Y
- 86Y-CHX-A''-Diethylenetriamine pentaacetic acid-bevacizumab
- 86Y-CHX-A''-Diethylenetriamine pentaacetic acid-cetuximab
- 86Y-CHX-A''-diethylenetriamine pentaacetic acid-panitumumab
- 86Y-CHX-A”-Rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13
- 86Y-DOTA-[Pro1,Tyr4]-Bombesin[1-14]
- 86Y-DOTA-rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13
- 89Zr
- 89Zr-Desferrioxamine-anti-CD105 TRC105 chimeric monoclonal antibody
- 89Zr-Desferrioxamine-anti-epithelial glycoprotein-1 hRS7 humanized monoclonal antibody
- 89Zr-Desferrioxamine B-7E11 anti-prostate-specific membrane antigen monoclonal antibody
- 89Zr-Desferrioxamine B-J591 anti-prostate-specific membrane antigen monoclonal antibody
- 89Zr-Desferrioxamine B-Transferrin
- 89Zr-Desferrioxamine p-isothiocyanatobenzyl-anti-EGFR nanobody 7D12
- 89Zr-Desferrioxamine p-isothiocyanatobenzyl-anti-hepatocyte growth factor nanobody 1E2 fused to albumin-binding nanobody Alb8
- 89Zr-Desferrioxamine p-isothiocyanatobenzyl-anti-hepatocyte growth factor receptor 1-armed antibody onartuzumab
- 89Zr-Labeled fresolimumab (human anti-transforming growth factor-β monoclonal antibody)
- 89Zr-Labeled N-succinyldesferrioxamine-ranibizumab
- 89Zr-Labeled N-suc-desferrioxamine-conjugated anti-carbonic anhydrase IX chimeric monoclonal antibody cG250-F(ab’)2 fragments
- 89Zr-Labeled p-isothiocyanatobenzyl-desferrioxamine B (Df-Bz-NCS)–conjugated panitumumab, a fully human monoclonal antibody directed against the extracellular domain III of the epidermal growth factor receptor
- 89Zr-Labeled trastuzumab, a humanized monoclonal antibody against epidermal growth factor receptor 2
- 89Zr-N-Succinyldesferal-anti-CD44v6 chimeric monoclonal antibody U36
- 89Zr-N-Succinyldesferal-chimeric monoclonal antibody G250
- 89Zr-N-Succinyldesferal-human anti-insulin-like growth factor 1 receptor monoclonal antibody R1507
- 89Zr-N-Succinyldesferrioxamine-bevacizumab
- 89Zr-N-Succinyldesferrioxamine-DN30
- 11C
- SPECT
- 111In
- [111In]5-[(3aR,6S,6aS)-2-Oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-6-yl]pentanoic acid
- [111In]-DOTA-Aminohexanoyl-[D-Phe6,Leu-NHCH2CH2CH313,desMet14] BBN[6-14]
- [111In]-Ethylenedicysteine-murine anti-phosphotyrosine antibody
- [111In]Labeled-(NAc-dD-CHA-F-dS-dR-Y-L-W-S-βAla)2-K-K(DOTA)
- [111In]-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-heat-stable human Escherichia coli enterotoxin
- [111In]-Labeled chimeric monoclonal antibody cG250 directed against carbonic anhydrase IX
- [111In]-Labeled divalent Fab fragment of chimeric monoclonal antibody cG250 directed against carbonic anhydrase IX
- [111In]-Labeled monovalent Fab fragment of chimeric monoclonal antibody cG250 directed against carbonic anhydrase IX
- [111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Pro1,Tyr4]Bombesin
- [111In-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-10-maleimidoethylacetamide-Cys61]-Affibody ZHER2:2395
- [111In-Diethylenetriamine pentaacetic acid-ACMpip5,Tha6,βAla11,Tha13,NIe14]bombesin(5-14)
- [111In-Diethylenetriaminepentaacetic acid-Pro1,Tyr4]bombesin
- 111In/125/131I-Labeled anti-mucin-1 murine, chimeric or humanized antibody hPAM4
- 111In/125I/99mTc-Labeled N-terminus tri-(histidine-glutamate) (HE)3-tagged and N- or C-terminus hexahistidine (H6)-tagged anti-epidermal growth factor receptor Affibody ZHER2:342-C
- 111In/86Y-Labeled F(ab')2 fragment of panitumumab, a fully human monoclonal antibody directed against the extracellular domain III of the epidermal growth factor receptor
- 111In-(1-isothiocyanatobenzyl-3-methyldiethylenetriaminepentaaetic acid)-anti–TAG-72 humanized CH2 domain-deleted antibody
- 111In-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Ac-RWQPCPAESWT-Cha-CWDPGGGK-NH2 (FibPep)
- 111In-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-anti-insulin-like growth factor 1 receptor Affibody ZIGF1R:4551
- 111In-1,4,7,10-Tetraazacyclododecane-1,4,7,10-triacetic acid-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
- 111In-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid-L-homoalanine
- 111In-1,4,7,10-tetraazacyclododecane-1,4,7-tris-acetic acid-10-maleimidoethylacetamide-Affibody ZHER2:2395-Cys
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-AB.Fab4D5
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid- Affibody ZHER2:342-pep2
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-cyclo(D-diaminobutyric acid-Arg-Phe-Phe-D-Trp-Lys-Thr-Phe)
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-LLP2A
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-T84.66 diabody
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-T84.66 minibody
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-T84.66 scFv-human serum albumin
- 111In-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-NDECELCVNVACTGCL
- 111In-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-Glu-[cyclo(Arg-Gly-Asp-d-Phe-Lys)]2
- 111In-2-(4,7,10-Tris(carboxymethyl)-1,4,7,10-tetracyclododecan-1-yl)pentanedioic acid-Trastuzumab
- 111In-2-(p-isothiocyanatobenzyl)-6-methyl-diethylenetriamine-N,N,N´,N´´,N´´-pentaacetic acid-trastuzumab
- 111In-Anti-CD105 MJ7/18 monoclonal antibody
- 111In-Benzyl-diethylenetriamine pentaacetic acid-AMB8LK
- 111In-Benzyl-diethylenetriaminepentaacetic acid-ZHER2:342
- 111In-Benzyl-tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-ZHER2:342
- 111In-BZ-Diethylenetriaminepentaacetic acid-ZEGFR:1907
- 111In-Capromab pendetide
- 111In-CHX-A''-DTPA-anti-mindin/RG-1 monoclonal antibody 19G9
- 111In-CHX-A”-diethylenepentaacetic acid-Affibody ZHER2:2395-Cys
- 111In-CHX-A”-Diethylenetriamine pentaacetic acid-(ZEGFR:955)2
- 111In-CHX-A”-Rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13
- 111In conjugated to benzyl-diethylenetriaminepentaacetic acid-human epidermal growth factor
- 111In-Diethylenetriaminepentaacetic acid-2-(p-isothiocyanatobenzyl)-6-methyl-B3 monoclonal antibody
- 111In-Diethylenetriaminepentaacetic acid-2C5 monoclonal antibody
- 111In-Diethylenetriaminepentaacetic acid-aminohexanoic acid-Lys40-exendin-4
- 111In-Diethylenetriamine pentaacetic acid-anti-epithelial glycoprotein-1 hRS7 humanized monoclonal antibody
- 111In-Diethylenetriamine pentaacetic acid-Anti-ligand–induced binding sites (LIBS) single-chain (scFv) antibody
- 111In-Diethylenetriamine pentaacetic acid-bevacizumab
- 111In-Diethylenetriaminepentaacetic acid-cyclo(CTTHWGFTLC)
- 111In-Diethylenetriamine pentaacetic acid-human anti-insulin-like growth factor 1 receptor monoclonal antibody R1507
- 111In-Diethylenetriamine pentaacetic acid-human epidermal growth factor
- 111In-Diethylenetriamine pentaacetic acid-IC2 rat monoclonal autoantibody to pancreatic β-cell surface antigen
- 111In-Diethylenetriaminepentaacetic acid-Lys40-exendin-3
- 111In-Diethylenetriamine pentaacetic acid-NAVPNLRGDLQVLAQKVART
- 111In-Diethylenetriamine pentaacetic acid-pertuzumab
- 111In-Diethylenetriaminepentaacetic acid-polyethylene glycol-annexin V
- 111In-Diethylenetriamine pentaacetic acid-QKYGNQWAVGHLM-NH2
- 111In-Diethylenetriamine pentaacetic acid-single-walled nanotubes
- 111In-Diethylenetriaminepentaacetic acid-trastuzumab
- 111Indium-diethylenetriaminepentaacetic acid-d-phenylalanine-octreotide
- 111Indium-diethylenetriaminepentaacetic acid-folate
- 111In-DOTA-4-amino-1-carboxymethyl-piperidine-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2
- 111In-DOTA-Gly-benzoyl-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2
- 111In-DOTA-Re(Cys3,4,10,d-Phe7,Arg11)αMSH3-13
- 111In-DPC11870
- 111In-DTPA-Poly(ethylene glycol)-anti-epidermal growth factor receptor antibody C225
- 111In-Ibritumomab tiuxetan
- 111In-Labeled (7S)-26-(4-((1-((1-carboxy-5-(2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)pentyl)amino)-1-oxo-6-(1-((7S)-1,3,7,22-tetracarboxy-5,13,20-trioxo-4,6,12,21-tetraazahexacosan-26-yl)-1H-1,2,3-triazole-4-carboxamido)hexan-2-yl)carbamoyl)-1H-1,2,3-triazol-5-yl)-5,13,20-trioxo-4,6,12,21-tetraazahexacosane-1,3,7,22-tetracarboxylic acid
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated dimeric [Tyr3]octreotide
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated monomeric [Tyr3]octreotide
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-regioselectively addressable functionalized template-[cyclo-(Arg-Gly-Asp-d-Phe-Lys)]4
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-VENK[homoC]NKEMRNRYWEAALDPNLNNQQKRAKIRSIYDDP[homoC]-NH2 with a disulfide bridge between the two homoC
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG4-Glu[cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)}-{PEG4-Glu[cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)} (PEG4 = 15 amino-4,7,10,13-tetraoxapentadecanoic acid)
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG4-Glu[cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)}-{PEG4-Glu[cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)} (PEG4 = 15 amino-4,7,10,13-tetraoxapentadecanoic acid)
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG4-Glu[cyclo(Lys-Arg-Gly-Asp-d-Phe)]-cyclo(Lys-Arg-Gly-Asp-d-Phe)}-{PEG4-Glu[cyclo(Lys-Arg-Gly-Asp-d-Phe)]-cyclo(Lys-Arg-Gly-Asp-d-Phe)} (PEG4 = 15 amino-4,710,13-tetraoxapentadecanoic acid)
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-d-Tyr-d-Lys(HSG)-d-Glu-d-Lys(HSG)-NH2 (IMP-288)
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-N,N’,N”,N’”-tetraacetic acid-GSC(succinimidopropionyl-EAYGWNleDF-NH2)-EAYGWNleDF-NH2
- 111In-Labeled Ac-Phe-Lys(DTPA)-Tyr-Lys(DTPA)-NH2 (IMP-156)
- 111In-Labeled affibody ABY-025 targeting epidermal growth factor receptor 2
- 111In-Labeled anti-CD44v6 chimeric monoclonal antibody U36
- 111In-Labeled anti-epidermal growth factor receptor Affibody PEP09239
- 111In-Labeled anti-epidermal growth factor receptor human monoclonal antibody 048-006
- 111In-Labeled chimeric monoclonal antibody, ch806, targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII)
- 111In-Labeled CHX-A''-DTPA–conjugated MORAb-009, a chimeric monoclonal antibody directed against mesothelin
- 111In-Labeled CHX-A”-DTPA conjugated monoclonal antibody (mAb) 806 targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII)
- 111In-Labeled diethylenetriamine-pentaacetic acid-Ac-TZ14011
- 111In-Labeled DOTA-conjugated 6-aminohexanoic linker-containing variant of anti-epidermal growth factor receptor 2 Affibody ZHER2:342 (ABY-003)
- 111In-Labeled DOTA-conjugated sCCK8[Phe2(p-CH2SO3H),Nle3,6], a sulfated cholecystokinin 8 (sCCK8) peptide derivative
- 111In-Labeled DTPA conjugated anti-c-kit monoclonal antibody 12A8 Fab fragment
- 111In-Labeled DTPA conjugated monoclonal antibody 12A8 that targets the c-kit receptor
- 111In-Labeled DTPA-conjugated Tat-linked anti-phosphorylated histone protein H2AX antibody
- 111In-Labeled human serum albumin–conjugated Affibody ZHER2:342 that targets the human epidermal growth factor receptor 2 (HER2)
- 111In-Labeled lexatumumab
- 111In-Labeled mapatumumab
- 111In-Labeled MLS128 anti-Tn murine monoclonal antibody
- 111In-Labeled panitumumab, a fully human monoclonal antibody directed against the extracellular domain III of the epidermal growth factor receptor
- 111In-Labeled recombinant gelonin toxin-B lymphocyte stimulator protein fusion protein
- 111In-p-Benzyl isothiocyanate-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-14C5 monoclonal antibody
- 111In-Streptavidin-biotinylated α-melanocyte-stimulating hormone 2.0 bacteriophage
- 111In-TA138
- 111In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-c(D-Cys-Phe-Tyr-D-AgI8(Me,2-naphthoyl)-Lys-Thr-Phe-Cys)-OH
- 111In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Glu-[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2
- 111In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Glu-{Glu-[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2}2
- 111In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Glu-cyclo(Arg-Gly-Asp-D-Phe-Lys)
- 111In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-MEDI-522
- 111In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Phe(4-NO2)-cyclo(D-Cys-Tyr-D-Trp-Lys-Thr-Cys)-D-Tyr-NH2
- 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-(GSG)-ANTPCGPYTHDCPVKR
- 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-Asp–Tyr(SO3H)–Met–Gly–Trp–Met–Asp–Phe–NH2
- 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid- d-Glu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2
- 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-dihistidine-norleucine peptide analog
- 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-HHEAYGWMDF-NH2 peptide
- 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-HHHHHH-EAYGWMDF-NH2 peptide
- 111In-Tetrameric Plectin-1 targeting peptide (4(βAKTLLPTP-GGS(PEG5000))KKK-111In-DOTA-βA-NH2)
- 111In-Trastuzumab Fab
- 4-[2-(3,4,5,6-Tetrahydropyrimidin-2-ylamino)ethyloxy]benzoyl-2-(S)-[N-3-amino-(SCN-Bz-DOTA-111In)-neopenta-1-carbamyl)]-aminoethylsulfonylamino-β-alanine
- Anti-mouse monoclonal antibody immunoglobulin G conjugated to GRKKRRQRRRPPQGYG-diethylenetriamine pentaacetic acid-[111In]
- Biotinylated anti-Tn MLS128 monoclonal antibody-streptavidin-111In-DTPA-biotin
- Lys-cys-cys-tyr-ser-leu-(gly-ser-gly)-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-111In
- Single-walled carbon nanotubes-111In-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-rituximab
- TA138-conjugated 111In nanoparticles
- 123I
- (1-Butyl-4-piperidinylmethyl)-8-amino-7-[123I]iodo-1,4-benzodioxan-5-carboxylate
- [123I]-2-Iodo-2-amino-3-phenylpropanoic acid
- [123I]Iomazenil
- [123I]Vascular endothelial growth factor
- [123I]-β-Methyl iodophenyl-pentadecanoic acid
- 1-(2,4-Dichlorophenyl)-5-(4-[123I]iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid N',N'-dimethyl-hydrazide
- 1(trans-[123I]Iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]piperidine
- 123/131I-Fab and F(ab')2 fragments of anti-integrin αvβ5 monoclonal antibody 14C5
- 123I-Annexin V
- 123I-Anti-vascular cell adhesion molecule monoclonal antibody 5F10
- 123I-Arg-Glu-Asn-Leu-Arg-Ile-Ala-Leu-Arg-Tyr
- 123I-c(RGDfK)-human serum albumin-tissue inhibitor of matrix metalloproteinase 2 fusion protein
- 123I-Interleukin-2
- 123I-Labeled (S)-2-(3-((S)-1-carboxy-5-(3-(4-iodophenyl) ureido)pentyl)ureido)pentanedoic acid
- 123I-Labeled (S)-2-(3-((S)-1-carboxy-5-(4-iodobenzylamino)pentyl)ureido)pentanedoic acid
- 2-(2-(4-(4-[123I]Iodobenzyl)piperazin-1-yl)-2-oxoethyl)isoindoline-1,3-dione
- 2β-Carbomethoxy-3β-(4´-((Z)-2-[123I]iodoethenyl)phenyl)nortropane
- 5-[123I]Iodo-3-[2(S)-2-azetidinylmethoxy]pyridine
- 6-Chloro-2-(4'-[123I]iodophenyl)-3-(N,N-diethyl)imidazo[1,2-a]pyridine-3-acetamide
- 7-(2-(4-(2-Fluoro-4-[123I]iodophenyl)piperazin-1-yl)ethyl)-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine
- 8-[123I]Iodo-L-1,2,3,4-tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid
- Mono-[123I]Iodohypericin
- Mono-[123I]iodohypericine monocarboxylic acid
- N-(2-(Diethylamino)ethyl)-5-[123I]iodonicotinamide
- N-(3-Fluoropropyl)-2β-carbomethoxy-3β-(4-[123I]iodophenyl)nortropane
- N-(Morpholin-4-yl)-5-(4-[123I]iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide
- 123I,125I
- [123I/125I]6-Iodo-2-(4´-dimethylamino)-phenyl-imidazo[1,2-a]pyridine
- 125I-Labeled chimeric monoclonal antibody, ch806, targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII)
- 125I-Labeled monoclonal antibody (mAb) 806 targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII)
- 2-((2-((Dimethylamino)methyl)phenyl)thio)-5-[123I]iodophenylamine
- Radioiodinated N-(2-diethylaminoethyl)-6-iodoquinoxaline-2-carboxamide dihydrochloride salt
- 123I, 131I
- 123I/125I/131I
- 125I
- (2S,αS)-2-(α-(2-[125I]Iodophenoxy)benzyl)morpholine
- [125I](E)-N-1-(3'-iodoallyl)-N'-4-(3'',4''-dimethoxyphenethyl)-piperazine
- [125I]2-Iodo-N-[(S)-{(S)-1-methylpiperidin-2-yl}(phenyl)methyl]3-trifluoromethyl-benzamide
- [125I]Anti-claudin 4 monoclonal antibody
- [125I]Anti-prostate stem cell antigen antibody
- [125I]-Labeled monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII)
- [125I]N-(4-Dipropylaminobutyl)-4-iodobenzamide
- [125I]N-[2-[N-Ethyl-N-[2-(2-fluoropyridin-3-yloxy)ethyl]amino]ethyl]-6-iodoquinoxaline-2-carboxamide dihydrochloride salt
- 125I-Anti-malondialdehyde-modified low-density lipoprotein monoclonal antibody
- 125I-Hydroxylated-single-walled nanotubes
- 125I-Labeled anti-epidermal growth factor receptor human Fab antibody fragment
- 125I-Labeled anti-mucin 1 bispecific antibody bsPAM4
- 125I-Labeled heparin-binding peptides that target heparan sulfate proteoglycans for the in vivo imaging of peripheral amyloidosis
- 125I Labeled-mesenchymal-epithelial transition factor binding peptide
- 125I-Labeled mesenchymal-epithelial transition factor binding peptide-8-aminooctanoic acid
- 125I-Labeled mesenchymal-epithelial transition factor binding peptide-Gly-Gly-Gly
- 125I-Labeled monoclonal antibody, mAb RM2, targeting the RM2 antigen
- 125I-Labeled monoclonal antibody PSA30
- 125I-Labeled mouse anti-human carbonic anhydrase IX monoclonal antibody
- 125I-Labeled murine anti-CD20 antigen monoclonal antibody NuB2 conjugated to one or three octaarginine (maleimide-(6-aminocaproic acid)2-(D-Arg)8-(D-Tyr)) peptide chains
- 125I-Labeled single-chain monoclonal antibody, NS4F5, that targets the GlcNS6S-IdoA2S motif of heparan sulfate proteoglycans for the in vivo imaging of peripheral amyloidosis
- 125I-Labeled trivalent, bispecific monoclonal antibody construct TF10 that targets mucin-1 and is reactive against a histamine-succinyl-glycine hapten IMP-288
- 125I-Radioiodinated tyrosine-folate and tyrosine-click-folate
- 125I-Single-chain antibody B1 targeting a pancreatic β-cell surface antigen
- 125I-Single-chain antibody B5 targeting a pancreatic β-cell surface antigen
- 125I-T84.66 scFv-human serum albumin
- 125I-Vascular endothelial growth factor-121
- 2-(4'-Dimethylaminophenyl)-6-[125I]iodobenzothiazole
- 2-{[4-(4-[125I]Iodobenzyl)piperidin-1-yl]methyl}benzimidazol-5-ol
- 3-(4-Hydroxy-3-[125I]iodophenyl)propionate-exendin(9-39)
- Biotinylated anti-Tn MLS128 monoclonal antibody-125I-streptavidin
- Fluorinated and iodinated (Z)-2-(4-(2-fluoroethoxy)benzylidene)-5-iodobenzofuran-3(2H)-one
- N,N-Diethyl-2-(2-(3-[125I]iodo-4-methyoxyphenyl)-5,7-dimethyl-pyrazolo(1,5-a)pyrimidin-3-yl)-acetamide
- N-{2-[4-(4-[125I]Iodobenzyl)-piperidin-1-ylmethyl]benzoimidazol-5-yl}-methanesulfonamide
- N1,N1-diethyl-N4-(7-[125I]iodoquinolin-4-yl)pentane-1,4-diamine
- Radioiodinated (1E,4E)-1-(4-aminophenyl)-5-(4-iodophenyl)penta-1,4-dien-3-one and (1E,4E)-1-(4-iodophenyl)-5-(4-(methylamino)phenyl)penta-1,4-dien-3-one
- Radioiodinated (Z)-2-(4-(2-hydroxyethoxy)benzylidene)-5-iodobenzofuran-3(2H)-one
- Radioiodinated anti-CD105 MAEND3 monoclonal antibody
- Radioiodinated anti–TAG-72 CC49 Fab’ antibody fragment
- Radioiodinated-anti–TAG-72 covalently linked CC49 divalent single-chain Fv antibody
- Radiolabeled (hetero)aromatic analogs of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and therapy of melanoma
- 125I/131I
- Radioiodinated anti-TAG-72 CC49 tetravalent single-chain Fv antibody
- Radioiodinated anti-TAG-72 humanized CH2 domain-deleted antibody
- Radioiodinated anti–TAG-72 non-covalently linked CC49 divalent single-chain Fv antibody
- Radioiodinated humanized monoclonal antibody A33
- Radioiodinated MLS128 anti-Tn murine monoclonal antibody
- 125mTe
- 131I
- [131I]N-(6-amino-2,2,4-trimethylhexyl)-2-[(5-iodo(3-pyridyl))carbonylamino]-3-(2-napthyl)propanamide
- 131I-Chlorotoxin
- 131I-Human recombinant anti-ED-B fibronectin antibody small immunoprotein
- 131I-Labeled [Z]-2-[4-(1,2-diphenyl-1-di-butenyl)-phenoxy]-N,N-dimethylethanamine
- 131I-Labeled anti-α folate receptor human antibody fragment AFRA-DMF5.3 dimer
- 131I-Labeled recombinant anti-glycoprotein A33 antibody single chain variable fragment fused to cytosine deaminase
- 131I-NP-4 anti-CEA monoclonal antibody
- 131I-Tositumomab
- 3'-(E)-(2-[123/131I]Iodovinyl)uridine
- N-(5-Fluoro-2-phenoxyphenyl)-N-(2-[131I]iodo-5-methoxybenzyl)acetamide
- N(ε)-(3-[131I]Iodobenzoyl)-Lys5-N(α)-maleimido-Gly1-GEEEK-anti-HER2 nanobody 5F7GGC
- R-2-[131I]Iodophenyl-(1-(1-methylpiperidin-2-ylmethyl)-1H-indol-3-yl)methanone
- Radioiodinated anti-DNA-histone 1 complex chimeric tumor necrosis therapy (TNT) monoclonal antibody 1
- 131I, 123I, 125I
- 131I, 125I
- 170Tm
- 177Lu
- [177Lu]-Labeled (S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-tetraacetic acid (C-DOTA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII)
- [177Lu]-Labeled [(R)-2-amino-3-(4-isothiocyanatophenyl)propyl]-trans-(S,S)-cyclohexane-1,2-diamine-pentaacetic acid (CHX-A″-DTPA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII)
- [177Lu]-Labeled 2-(4-isothiocyanatobenzyl)-6-methyldiethylene-triaminepentaacetic acid (1B4M-DTPA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII)
- [177Lu]-Labeled α-(5-isothiocyanato-2-methoxyphenyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (MeO-DOTA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII)
- 177Lu-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid-human serum albumin-Ac-Cys-ZEGFR:1907
- 177Lu-Benzyl-diethylenetriamine pentaacetic acid-anti-carbonic anhydrase IX small immunoprotein A3
- 177Lu-CHX-A''-DTPA-ABD-Affibody (ZHER2:342)2
- 177Lu-DOTA-Gly-4-aminobenzoyl-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
- 177Lu-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-Tyr-cyclo(DAB-Arg-cyclo(Cys-Phe-d-Trp-Lys-Thr-Cys))
- 177Lu-Labeled aglycosylated anti-L1-CAM monoclonal antibody chCE7
- 177Lu-Labeled DOTA-conjugated AE105 peptide (Asp-Cha-Phe-(d)Ser-(d)Arg-Tyr-Leu-Trp-Ser-CONH2)
- 177Lu-Labeled ethylenediamine tetramethylene phosphonic acid
- 177Lu-Labeled h-R3 (nimotuzumab), a humanized monoclonal antibody targeting the external domain of the epidermal growth factor receptor
- 177Lu-Labeled humanized monoclonal antibody against human epidermal growth factor receptor 2
- 177Lu-Labeled methylene diphosphonate
- 177Lu-Labeled sodium pyrophosphate
- 186Re
- 188Re
- 211At
- 67Ga
- 67Ga-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-Gly-Glu-c[Lys-Nlc-Glu-His-d-Phe-Arg-Trp-Gly-Arg-Pro-Val-Asp]
- 67Ga labeled cyclic diethylenetriamine pentaacetic acid Insulin
- 67Ga-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-3-{2-[2-(3-amino-propoxy)-ethoxy]-ethoxy}-propylamine-γ-folate
- 99mTc
- [2[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]-oct-2-yl]-methyl](2-mercaptoethyl)amino]ethyl]amino]ethanethiolato(3-)-N2,N2’,S2,S2]oxo-[1R-exo-exo)])- [99mTc]-technetium
- [99mTc/90Y]-1,4,7,10 Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid phenylalanine derivative conjugated to anti-epidermal growth factor receptor antibody ior egf/r3
- [99mTc(CO)3]+-Labeled anti-epidermal growth factor receptor (HER2) affibody ZHER2:342 with a hexa-histidine tag (H6) on the C-terminal
- [99mTc(CO)3]+-Labeled anti-epidermal growth factor receptor (HER2) affibody ZHER2:342 with a hexa-histidine tag (H6) on the N-terminal
- [99mTc(CO)3]+-Labeled anti-epidermal growth factor receptor (HER2) affibody ZHER2:342 with a tri-(histidine-glutamate) peptide tag (HE)3 on the N-terminal
- [99mTc(N)(NS-Cys-Gly-CCK-8)(PNP3)]+
- [99mTc](CO)3N-(pyridin-2-yl-methyl)-N[2-(4-sulfamoylphenyl)-ethyl]aminoethyl acetate
- [99mTc]1,4,7,10-tetraazacyclododecane-N, N’, N’’, N’’’-tetraacetic acid-Phe-Lys-histamine-succinyl-Gly-D-Tyr-Lys- histamine-succinyl-Gly-thiosemicarbazonyl-glyoxyl-cysteine
- [99mTc]-1,4,7,10-Tetraazacyclododecane tetramethylenephosphonic acid
- [99mTc]4-Dithiocarbamato-N-benzylpiperidine
- [99mTc]-Acetyl-arg-arg-arg-arg-arg-cys-gly-cys-gly-gly-pro-leu-tyr-arg-arg-ile-ile-arg-arg-leu-leu-glu-ser-dermatan sulfate
- [99mTc]Anti-CD3 monoclonal antibody
- [99mTc]Cyclo(L-homocysteinyl-N-methyl-L-phenylalanyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl), (1‡1´)-sulfide with 3-[(mercaptoacetyl)amino]-L-alanyl-L-lysyl-L-cysteinyl-L-lysinamide
- [99mTc]-diethylenetriaminepentaacetic acid-galactosyl human serum albumin
- [99mTc]Epidermal growth factor receptor–specific nanobody
- [99mTc]Human telomerase reverse-transcriptase antisense mRNA oligonucleotide
- [99mTc]-Mercaptoacetyldiglycyl-1,5-diaminopentylene hypericincarboxamide
- [99mTc]-Pentavalent dimercaptosuccinic acid
- [99mTc]Vasoactive intestinal peptide-aminobutyric acid-Gly-Gly-(D)-Ala-Gly
- [99mTc-Gly-Gly-Cys]-Ornithine-ornithine-ornithine-cyclo(Arg-Gly-Asp-d-Phe-Lys)
- [99mTc-N40-1-bzlg0,D-Phe6,Leu-NHEt13,des-Met14]Bombesin(6–14)
- 99mTc/111In-Labeled DTPA-succinyl polylysine
- 99mTc/188Re-Labeled dipicolylamine-alendronate
- 99mTc-(3Z)-4-{4-[2-(Dimethylamino)ethoxy]phenyl}-3,4-diphenylbut-3-en-1-ylN,N-bis[2-(2,6-dioxomorpholin-4-yl)ethyl]glycinate
- 99mTc(CO)3-((S-Pyridin-2-ylmethyl)-Cys)-Nle-Asp-His-d-Phe-Arg-Trp-Gly-Lys-NH2
- 99mTc(CO)3-Anti-carcinoembryonic antigen (CEA) humanized CEA5 graft nanobody
- 99mTc(CO)3-Anti-epidermal growth factor receptor nanobody 8B6
- 99mTc(CO)3-Anti-vascular cell adhesion molecule-1 nanobody cAbVCAM1-5
- 99mTc(CO)3-Bipyridine-cyclo-(Arg-Gly-Asp-D-Tyr-Lys)
- 99mTc(CO)3-Pyrazolyl-cyclo(Arg-Gly-Asp-D-Tyr-Lys)
- 99mTc-(Hydrazinonicotinic acid-duramycin)(tricine)(TPPTS)
- 99mTc-(Hydrazinonicotinic acid-β-Ala-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2)(tricine)(TPPTS)
- 99mTc-(NαHis)Ac-(Arg-N-CH3)-Arg-Pro-(dimethyl-Tyr)-(tertary-Leu)-Leu
- 99mTc-(RR,SS)-4,8-diaza-3,6,6,9-tetramethylundecane-2,10-dione bisoxime
- 99mTc(v)O-Gly-Gly-Cys-Orn-Orn-Orn-Bombesin[2-14]
- 99mTc-[Ac-CCEHdFRWCKPV-NH2]
- 99mTc-[Cys3,4,10,d-Phe7,Arg11]α-MSH3-13
- 99mTc-1,4,7-Tris(carboxymethyl)-10-(4-aminoethyl)-1,4,7,10-tetraazacyclododecane-Folate
- 99mTc-2-[Bis-(2-mercaptoethyl)]aminoethanethiol-4-isocyano-N-[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]butanamide
- 99mTc-2-Methoxyisobutylisonitrile
- 99mTc-Acetyl-Asn-Gln-Glu-Gln-Val-Ser-Pro-3-iodo-Tyr-Thr-Leu-Leu-Lys-Gly-NC100194
- 99mTc-Ac-Lys(DTPA)-Tyr-Lys(DTPA)-Lys(thiosemicarbazonyl-glyoxyl-cysteinyl-)-NH2 (IMP-192)
- 99mTc-Affibody ZHER2:2395-Cys
- 99mTc-Anti-CD105 E9 monoclonal antibody
- 99mTc-Anti-ED-B fibronectin L19-(Gy)3-Cys-Ala scFv antibody fragment
- 99mTc-Anti-ED-B fibronectin single-chain antibody fragment L19-Hi20
- 99mTc-Anti-ED-B fibronectin single-chain antibody fragment L19-His
- 99mTc- anti-EGFR monoclonal antibody h-R3
- 99mTc-Arcitumomab
- 99mTc-Bis-amino-bis-thiol-conjugated 6-(3-bromopropoxy)-2-(4-(dimethylamino)phenyl)-4H-chromen-4-one and (Z)-5-(3-bromopropoxy)-2-(4-(dimethylamino)benzylidene)benzofuran-3(2H)-one
- 99mTc-CCND1-PNA-IGF1 Chimeras
- 99mTc-Cys-Gly-Gly-Affibody ZHER2:342
- 99mTc-Diamine dioxime-Lys-Cys-Arg-Gly-Asp-Cyc-Phe-Cys-polyethylene glycol
- 99mTc-Diethylenetriaminepentaacetate-deoxyglucose
- 99mTc-Diethylenetriamine pentaacetic acid–lactosyl human serum albumin
- 99mTc-Diethylenetriaminepentaacetic acid-mannosyl-dextran
- 99mTc-Diethylenetriamine pentaacetic acid superparamagnetic iron oxide nanoparticles conjugated with lactobionic acid
- 99mTc-Ethylenediaminediacetic acid/hydrazinonicotinamide-[dGlu1]minigastrin
- 99mTc-Ethylenediaminediacetic acid/hydrazinonicotinic acid-[dGlu1, desGlu2–6]minigastrin
- 99mTc-Ethylenediaminediacetic acid/hydrazinonicotinic acid-cyclo(Arg-Gly-Asp-D-Try-Lys)
- 99mTc-ethylenediamine N,N’-diacetic acid/hydrazinonicotinamide-Tyr3-octreotide
- 99mTc-Ethylenedicysteine-C225
- 99mTc-Ethylenedicysteine-deoxyglucose
- 99mTc-Ethylenedicysteine-endostatin
- 99mTc-Ethylenedicysteine-folate
- 99mTc-Ethylenedicysteine-guanine
- 99mTc-Ethylenenediamine-N,N'-diacetic acid/hydrazinonicotinamide[Lys3]-bombesin
- 99mTc-Fucoidan, a polysaccharidic ligand of P-selectin
- 99mTc-Galactosyl-methylated chitosan
- 99mTc-Glucosamine-multiwall carbon nanotubes
- 99mTc-Glucosamino-Asp-cyclo(Arg-Gly-Asp-D-Phe-Lys)
- 99mTc-glutamate peptide 3-aminoethyl estradiol
- 99mTc-Gly-Gly-Cys-(Arg)3-bombesin(2-14)-NH2
- 99mTc-Hexamethylpropyleneamine oxime-blue-biotin-liposomes
- 99mTc-Hexamethylpropyleneamine oxime pH-sensitive liposomes
- 99mTc-Human β-defensin-3
- 99mTc-Hydrazinonicotinamide/tricine-eighteen-nucleotide RIα mRNA antisense small interfering oligoribonucleotides
- 99mTc-Hydrazinonicotinamide-aminohexanoic acid-Lys40-exendin-4
- 99mTc-Hydrazinonicotinamide-annexin V
- 99mTc-Hydrazinonicotinamide-anti-TAG-72 CC49 divalent single-chain Fv monoclonal antibody
- 99mTc-Hydrazinonicotinamide-anti-TAG-72 CC49 tetravalent single-chain Fv monoclonal antibody
- 99mTc-Hydrazinonicotinamide-chitosan-anti-vascular endothelial growth factor receptor 2 monoclonal antibody DC101
- 99mTc-Hydrazinonicotinamide-epidermal growth factor
- 99mTc-Hydrazinonicotinamide-galactosyl-chitosan
- 99mTc-Hydrazinonicotinamide-interleukin-8
- 99mTc-Hydrazinonicotinic acid-bitistatin
- 99mTc-Hydrazinonicotinic acid-cyclo[γ-d-Glu-Ala-Tyr-d-Lys]-Trp-Met-Phe-NH2
- 99mTc-Hydrazinonicotinic acid-Glu-[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2
- 99mTc-Hydrazinonicotinic acid-Glu-{Glu-[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2}2
- 99mTc-Hydrazinonicotinic acid-single-chain Cys-tagged vascular endothelial growth factor-121
- 99mTc-Hydrazinonicotinyl(tricine)(TPPTS)-Glu-c(RGDyK)-bombesin[7-14]NH2
- 99mTc-Interleukin-18-binding protein-Fc-interlukin-1 receptor antagonist
- 99mTc-Interleukin-2
- 99mTc-Labeled, PEGylated (NαHis)Ac-β3hLys-βAla-βAla-Gln7-Trp8-Ala9-Val10-Gly11-His12-Cha13-Nle14-NH2
- 99mTc-Labeled (1S,3S)-3-acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-α-l-lyxo-hexopyranoside
- 99mTc-labeled [N40,Pro1,Tyr4]bombesin
- 99mTc-Labeled 13,13’[oxybis[methylene(2,5-dioxo-1,3-pyrrolidinediyl)]]bis[N-(mercaptoacetyl)-D-tyrosyl-S-(3-aminopropyl)-L-cysteinylglycyl-L-α-aspartyl-L-cysteinylglycylglycyl-S-[(acetylamino)methyl]-L-cysteinylglycyl-S-[(acetylamino)methyl-L-cysteinylglycylglycyl-L-cysteinamide],cyclic(1→5),(1’→5’),-bis(sulfide)
- 99mTc-Labeled 1-hydroxy-2-(2-ethyl-4-methyl-1H-imidazol-1-yl)ethane-1,1-diyldiphosphonic acid
- 99mTc-Labeled 1-hydroxy-2-(2-isopropyl-1H-imidazole-1-yl)ethylidene-1,1-bisphosphonic acid
- 99mTc-Labeled 1-hydroxy-3-(1H-imidazol-1-yl)propane-1,1-diyldiphosphonic acid (IPrDP)
- 99mTc-Labeled 5-amino-1,3-bis(ethylamine-(N,N-dimethyl diphosphonic acid)acetamido)benzene
- 99mTc-Labeled 6-hydrazinopyridine-3-carboxylic acid (HYNIC)–conjugated murine anti-MUC1 monoclonal antibody PR81
- 99mTc-Labeled 6-hydrazinopyridine-3-carboxylic acid conjugated to hydroxy-bisphosphonate
- 99mTc-Labeled acetylated dendrimer poly(amido)-amine generation 5-folic acid-2-(p-isothiocyanatobenzyl)-6-methyl-diethylenetriamine pentaacetic acid conjugate
- 99mTc-Labeled acetylated dendrimer poly(amido)-amine generation 5-PEGylated folic acid-2-(p-isothiocyanatobenzyl)-6-methyl-diethylenetriamine pentaacetic acid conjugate
- 99mTc-Labeled anti-carcinoembryonic antigen monoclonal antibody CL-58
- 99mTc-Labeled anti-macrophage mannose receptor (MMR; CD206) nanobody
- 99mTc-Labeled anti-receptor for advanced glycation endproducts monoclonal antibody F(ab’)2 fragments
- 99mTc-Labeled anti-receptor for advanced glycation endproducts polyclonal antibody F(ab’)2 fragments
- 99mTc-labeled anti-tumor necrosis factor-alpha monoclonal antibody
- 99mTc-Labeled citric acid-folate conjugate
- 99mTc-Labeled cysteine-tagged dimeric epidermal growth factor
- 99mTc-Labeled cysteine-tagged epidermal growth factor
- 99mTc-Labeled doxorubicin
- 99mTc-Labeled hydrazinonicotinamide-cysteine-annexin A5
- 99mTc-Labeled imine 6-(pyridine-2-methylimine)-4-[(3-bromophenyl)amino]quinazoline
- 99mTc-labeled ior-egf/r3 monoclonal antibody against epidermal growth factor receptor
- 99mTc-Labeled lexatumumab
- 99mTc-Labeled mannosylated dextran DCM20
- 99mTc-Labeled mapatumumab
- 99mTc-Labeled mercaptoacetylglycylglycylglycine conjugated to hydroxy-bisphosphonate
- 99mTc-Labeled murine IgM monoclonal antibody, fanolesomab, that targets the CD15 glycoprotein antigen
- 99mTc-Labeled N-(triethylammonium)-3-propyl-[15]ane-N5
- 99mTc-Labeled Nε49 mercaptoacetyl derivatives of affibody ZHER2:342 targeting the human epidermal growth factor receptor
- 99mTc-Labeled O-[3-(1,4,8,11-tetraazabicyclohexadecane)-propyl]-α-methyl tyrosine
- 99mTc-Labeled peptide derivative of folic acid
- 99mTc-Labeled poly(ethyleneglycol)–N-(N-(3-diphenylphosphinopropionyl)glycyl)-S-tritylcysteine (PEG-PN2S)-linked ubiquicidin (UBI)
- 99mTc-Labeled pyridyl benzofuran derivatives to target β-amyloid plaques
- 99mTc-Labeled rituximab, a chimeric murine/human anti-CD20 monoclonal antibody
- 99mTc-Labeled S-benzoylmercaptoacetyl triglycine d-galactose
- 99mTc-Labeled S-benzoylmercaptoacetyl triglycine d-glucose
- 99mTc-Labeled S-benzoylmercaptoacetyl triglycine n-acetylglucosamine
- 99mTc-Labeled succinimidyl-6-hydrazinonicotinate hydrochloride (SHNH)-conjugated visilizumab
- 99mTc-Labeled tetraethylenepentamine-folate
- 99mTc-Labeled trans-1,2-cyclohexyldinitrilo tetramethylene phosphonic acid
- 99mTc-Labeled tumor-associated glycoprotein 72 binding peptides A2-6 and A3-10
- 99mTc-Labeled tumor-associated glycoprotein 72 binding peptides G3-15 and T3-15
- 99mTc-Mercaptoacetyl-Glu-Glu-aptamer specific for tenascin-C
- 99mTc-Mercaptoacetyl-Glu-Glu-Glu-Affibody ZHER2:342
- 99mTc-Mercaptoacetyl-Gly-Gly-Gly-Affibody ZHER2:342
- 99mTc-Mercaptoacetyl-Gly-Gly-Gly-PAP-1
- 99mTc-Mercaptoacetyl-Ser-Ser-Ser-Affibody ZHER2:342
- 99mTc-Methyl diphosphonate
- 99mTc-Monocyte chemoattractant protein-1
- 99mTc-N,N'-Bis(S-benzoyl-thioglycoloyl)diamidopropanoyl-KRAS-PNA-d(Cys-Ser-Lys-Cys)
- 99mTc-N2S2-Tat(49-57)-Lys3-bombesin
- 99mTc-Nicotinic acid/tricine/hydrazinonicotinamide-nonsulfated cholecystokinin-8
- 99mTc-Nicotinic acid/tricine/hydrazinonicotinamide-sulfated cholecystokinin-8
- 99mTcO-N,N-Dimethylglycyl-l-lysinyl-l-cysteinylamide-8-amino-3,6-dioxaoctanoic-probestin
- 99mTc-pGlu-Gln-Trp-Ala-Val-Gly-His-Phe-Met-NH2
- 99mTc-Regioselectively addressable functionalized template-[cyclo-(Arg-Gly-Asp-d-Phe-Lys)]4
- 99mTc-S-acetylmercaptoacetyltriserine-stromal-derived factor 1α
- 99mTc-succinimidyl-6-hydrazinopyridine-3-carboxylate-interleukin 12
- 99mTc-Tricarbonyl-His6-annexin A5
- 99mTc-Tricarbonyl-K-H-K-H-cholecystokinin 8
- 99mTc-Tricarbonyl–labeled aspartic-N-monoacetic acid (ASMA)
- 99mTc-Type II tumor necrosis receptor-Fc-interlukin-1 receptor antagonist fusion protein
- 99mTc-Ubiquicidin29-41
- 99mTc≡Nitrido(diphosphine)-Cys-β-Ala-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
- Acetyl-lys-lys-lys-lys-lys-cys-gly-cys-gly-gly-pro-leu-tyr-lys-lys-ile-ile-lys-lys-leu-leu-glu-ser-heparin-[99mTc]
- N-[2-(N-(2-mercaptoethyl)) amino ethyl]-N-(2-mercaptoethyl)-3,5-dimethylacetamide amantadine-technetium
- Tricarbonyl[99mTc]technetium(I)-((S)-6-(8-(bis(pyridin-2-ylmethyl)amino)octanamido)-2-((S)-1-carboxy-3-phenylpropylamino)hexanoyl)pyrrolidine-2-carboxylic acid
- Tri-methoxy-tris-pyrazolyl-99mTc-(CO)3
- 111In
- Ultrasound
- Dye
- Gold
- ICG
- Microbubbles
- Abciximab microbubbles
- Air-filled, cross-linked, human serum albumin microcapsules
- Anti-ligand–induced binding sites (LIBS) single-chain antibody conjugated to microbubbles
- Anti-vascular cell adhesion molecule-1 monoclonal antibody M/K-2.7 microbubbles
- Buried cyclo(Arg-Gly-Tyr(Me)-Lys-Glu) microbubbles
- Magnetic microbubbles conjugated with anti-vascular cell adhesion molecule-1 monoclonal antibody 429
- Microbubble-conjugated vascular endothelial growth factor receptor 2 binding peptide
- Microbubble-conjugated vascular endothelial growth factor receptor 2 monoclonal antibody
- Microbubbles coated with antibody to intracellular adhesion molecule-1
- Microbubbles coated with antibody to mucosal addressin cellular adhesion molecule-1
- Microbubbles coated with anti-P-selectin antibody RB40.34
- Microbubbles coated with biotinylated rabbit anti-mouse endoglin monoclonal antibody
- Microbubbles coated with biotinylated rabbit anti-mouse vascular endothelial growth factor receptor 2 (VEGFR-2) monoclonal antibody
- Microbubbles coated with biotinylated rabbit anti-mouse αVβ3 integrin monoclonal antibody
- Microbubbles conjugated with anti-matrix metalloproteinase 2 mouse monoclonal antibody sc-13595
- Microbubbles conjugated with anti-vascular cell adhesion molecule-1 nanobody cAbVCAM1-5
- Microbubbles conjugated with cyclo(CGGRRLGGC)
- Microbubbles conjugated with knottin 2.5D
- Microbubbles conjugated with single-chain Cys-tagged vascular endothelial growth factor-121
- Microbubbles-echistatin
- Microbubbles with a disteroylphosphatidylcholine, disteroylphosphatidylethanolamine-polyethyleneglycol (PEG) 2000-pyridyldithio propionate-PEG 40 stearate shell conjugated to cyclic arginine-glycine-aspartic acid-d-tyrosine-lysine (cRGD) pentapeptide
- Perflexane-Lipid Microspheres
- Perflutren lipid microspheres
- Sonicated human serum microspheres
- Stabilized sulfur hexafluoride microbubbles
- Nanobubbles
- X-Ray, CT
- Au
- Bi
- Iodine
- (S)-N,N’-bis[2-hydroxy-1-(hydroxymethyl)-ethyl-2,4,6-triiodo-5-lactamidoisophthalamide
- 1,3-Bis-[7-(3-amino-2,4,6-triiodophenyl)-heptanoyl]-2-oleoyl glycerol
- 5-[3-Hydroxy-2-hydroxymethyl-propionamido)-N,N´-dimethyl-N,N´-bis-(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide
- Ethyl-3,5-bis(acetylamino)-2,4,6-triiodobenzoate nanoparticles
- Ioxilan carbonate particles
- Lipiodol-loaded poly(oxyethylene)-block-poly(oxypropylene)-block-poly(oxyethylene) triblock copolymers/polyethylene glycol-nanoparticles
- N,N´-Bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)-glycolamidol]-2,4,6-triiodoisophthalamide
- N,N´-Bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl-3-methoxypropyl)-acetamidol]-2,4,6-triiodoisophthalamide
- N-(2,3-Dihydroxypropyl)-N´-(2-hydroxyethyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodoisophthalamide
- Sodium-2-[(3-butanoylamino-2,4,6-triiodo-phenyl)methyl]butanoate